[{"text": "LIVE The latest news and updates on Trump's tariffs PREMIUM BioCryst Pharmaceuticals Preliminary Q4 Revenue Rises MT Newswires Fri, Jan 10, 2025, 6:02 PM In This Article: BCRX BioCryst Pharmaceuticals (BCRX) reported Friday preliminary Q4 revenue of $130.8 million, up 40% yea PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "BCRX", "date": "2025-01-10T18:02:55", "sentiment": {"score": 0.17752207722514868, "confidence": 0.1864900290966034, "probabilities": {"positive": 0.1864900290966034, "negative": 0.008967951871454716, "neutral": 0.8045420050621033}}, "embedding": [-0.10651056468486786, -0.02655726857483387, 0.07787707448005676, -0.08964342623949051, 0.009655625559389591, -0.02280559204518795, -0.018422143533825874, 0.1599111557006836, 0.005897538736462593, 0.0017922387924045324, -0.06068141758441925, 0.04784306138753891, 0.04567672312259674, 0.12366995960474014, -0.0337068997323513, 0.06753457337617874, 0.0919572189450264, -0.05555274710059166, -0.060040347278118134, 0.05847686529159546, -0.05168724060058594, -0.03509180247783661, 0.08039464801549911, 0.062495723366737366, 0.14302869141101837, 0.06927230209112167, -0.046735409647226334, -0.08342535048723221, 0.020050248131155968, -0.0645396038889885, 0.05109550803899765, 0.10714825242757797, 0.07654811441898346, -0.11229225993156433, 0.060922738164663315, -0.06409373134374619, 0.0061287605203688145, -0.04285098612308502, 0.060589805245399475, 0.06862570345401764, 0.09539099037647247, -0.15738816559314728, -0.2407665252685547, 0.07803729176521301, -0.009672502987086773, -0.08586989343166351, 0.024145854637026787, 0.0910707637667656, 0.16260720789432526, 0.06670275330543518, -0.15118202567100525, -0.06526413559913635, 0.10433481633663177, 0.05332287400960922, 0.014605928212404251, -0.09820986539125443, -0.14546802639961243, -0.13675914704799652, 0.14060358703136444, -0.022076556459069252, -0.00942477211356163, -0.13061195611953735, 0.04501333087682724, 0.11810623854398727, 0.04678873345255852, 0.08221394568681717, -0.11449730396270752, 0.004441393539309502, -0.12401261925697327, -0.1676524132490158, -0.04300146549940109, 2.0750860130647197e-05, 0.019812004640698433, 0.039060693234205246, 0.004791571293026209, 0.09503083676099777, 0.17253679037094116, 0.09579196572303772, 0.04994600638747215, -0.09084177017211914, 0.03942978009581566, -0.09452632814645767, -0.050450392067432404, -0.020867740735411644, 0.05182093009352684, -0.0626395046710968, 0.06082271412014961, -0.040481265634298325, 0.032594528049230576, -0.01918666437268257, 0.17854072153568268, -0.03126596659421921, 0.010409865528345108, -0.014445223845541477, -0.2352183312177658, -0.07378819584846497, -0.10798634588718414, -0.06694997847080231, 0.09820082038640976, 0.013232309371232986, 0.10203060507774353, -0.007837063632905483, -0.06516333669424057, -0.04607205092906952, -0.1114436462521553, -0.14260530471801758, -0.03513741120696068, 0.2641581892967224, 0.07672496140003204, 0.0776819959282875, -0.03461024537682533, 0.09935594350099564, -0.015201524831354618, -0.04056597501039505, -0.09971771389245987, 0.13609887659549713, -0.030636632815003395, -0.047270070761442184, 0.10972397774457932, -0.1137591078877449, 0.09947791695594788, 0.04871810972690582, -0.12745234370231628, -0.10104446858167648, 0.016041219234466553, -0.05323890596628189, -0.15652038156986237, 1.6158376203129873e-32, -0.0034106618259102106, 0.14922159910202026, 0.10565264523029327, -0.06278666108846664, -0.05232788994908333, 0.07266063243150711, 0.04621518775820732, -0.13761281967163086, -0.12313876301050186, -0.1995280534029007, -0.2298818975687027, 0.16352839767932892, -0.07904999703168869, 0.1296876221895218, -0.0881202295422554, -0.30073779821395874, -0.14746740460395813, -0.05567527562379837, 0.1497010439634323, 0.024739179760217667, 0.153811976313591, -0.12204372882843018, -0.004803977441042662, 0.15324844419956207, 0.03149425610899925, 0.16344928741455078, 0.0814824029803276, -0.08266916871070862, 0.09740045666694641, 0.060842905193567276, -0.14703287184238434, 0.08905980736017227, 0.029239624738693237, -0.14041337370872498, -0.03265063837170601, 0.10021359473466873, -0.030683742836117744, -0.026930097490549088, -0.05412007495760918, -0.01619069091975689, -0.05760302394628525, 0.07700403779745102, -0.011700226925313473, -0.028321797028183937, 0.01757596805691719, 0.02131173573434353, -0.06922793388366699, -0.021031131967902184, 0.11265861243009567, -0.18388424813747406, -0.06862636655569077, 0.05325660482048988, -0.11636526882648468, -0.13985596597194672, 0.04876888170838356, 0.0028099953196942806, -0.09833475202322006, -0.20757779479026794, 0.017225205898284912, 0.08344121277332306, 0.22636295855045319, 0.13671991229057312, -0.07261455059051514, 0.07671776413917542, -0.17507389187812805, 0.10698148608207703, 0.023529142141342163, 0.01322378870099783, -0.26819977164268494, 0.2534882426261902, 0.17692674696445465, -0.004788082558661699, 0.18421489000320435, -0.023229897022247314, -0.007908952422440052, 0.04332200810313225, -0.1192467212677002, -0.07579229027032852, 0.11593684554100037, 0.05478286370635033, 0.020243793725967407, -0.0511101633310318, 0.16024741530418396, 0.09230533242225647, 0.09547135978937149, -0.012179454788565636, 0.015972409397363663, -0.0033601687755435705, 0.07370901852846146, 0.14718985557556152, -0.07306764274835587, -0.16609737277030945, -0.10469979792833328, 0.10912252962589264, -0.22466325759887695, -1.5775964380920367e-32, 0.0036205193027853966, 0.1212044209241867, 0.15274667739868164, 0.001754945726133883, -0.19835615158081055, 0.013858777470886707, 0.038020484149456024, 0.22228360176086426, 0.23576697707176208, 0.0801442489027977, 0.0657106265425682, 0.1236950010061264, -0.028327127918601036, 0.17383423447608948, 0.022386843338608742, 0.012313272804021835, 0.09697867184877396, -0.14173302054405212, -0.23695148527622223, 0.012639256194233894, -0.08725805580615997, 0.1261645406484604, -0.2010965198278427, 0.20081819593906403, -0.00989261083304882, 0.05171980708837509, 0.17233462631702423, 0.2268267422914505, 0.039096295833587646, -0.07092497497797012, -0.2110818475484848, -0.158718079328537, -0.25015681982040405, -0.093174509704113, -0.06194109469652176, 0.08946254849433899, 0.14800193905830383, -0.004233755636960268, 0.12035425007343292, -0.09829189628362656, 0.09737402945756912, -0.1100916862487793, -0.1592259258031845, 0.09072237461805344, 0.09272477775812149, -0.0862741470336914, -0.13843387365341187, 0.085172638297081, 0.16473644971847534, 0.10926511883735657, -0.01161736436188221, 0.1432972103357315, 0.018130186945199966, 0.08679469674825668, -0.23756486177444458, -0.013902430422604084, -0.01585269533097744, 0.03765161335468292, -0.015851540490984917, -0.05207784101366997, 0.00423017144203186, 0.1111459732055664, -0.008062595501542091, -0.011225295253098011, -0.06090102344751358, -0.026933901011943817, 0.08078380674123764, -0.0764622762799263, 0.13547883927822113, -0.08030487596988678, 0.05955090373754501, -0.03564825281500816, -0.03146950155496597, -0.19342559576034546, 0.05899369344115257, 0.2498178780078888, -0.1935461461544037, -0.0622449666261673, -0.041272733360528946, 0.05486202985048294, 0.14006513357162476, -0.02182435244321823, 0.0972946360707283, -0.14005304872989655, 0.0036488815676420927, 0.05240882188081741, 0.1485259085893631, -0.06621397286653519, -0.06748678535223007, -0.018518812954425812, -0.153172105550766, -0.1671728640794754, -0.10576924681663513, 0.1971321403980255, 0.000699384487234056, -9.953507174031984e-08, 0.09728015214204788, -0.0423603281378746, -0.02952595241367817, -0.010078607127070427, 0.05324365198612213, -0.013543554581701756, -0.0762602910399437, -0.05329326167702675, 0.051041390746831894, 0.08802660554647446, 0.055516086518764496, 0.02397005818784237, -0.13580794632434845, 0.0006543121999129653, -0.03167494758963585, 0.08700733631849289, -0.08089271187782288, -0.017243092879652977, 0.024786749854683876, -0.2708538770675659, -0.03682161867618561, 0.1573074907064438, 0.10427261888980865, -0.021432526409626007, 0.13970355689525604, 0.017457829788327217, -0.041810210794210434, -0.02842792123556137, 0.10162501037120819, -0.02305084653198719, 0.016091732308268547, 0.0049541969783604145, -0.10924019664525986, -0.004858979489654303, 0.039937421679496765, -0.11389521509408951, -0.10096517950296402, 0.05446109548211098, 0.12580664455890656, 0.0546722412109375, 0.037992946803569794, -0.1638554036617279, -0.08253448456525803, 0.08067228645086288, -0.0981421023607254, -0.009502002038061619, -0.3468816876411438, -0.07793615013360977, 0.14983218908309937, -0.10453738272190094, 0.09573931992053986, -0.1151689812541008, 0.09799715131521225, -0.06367341428995132, 0.07658243924379349, 0.07308340072631836, -0.049009885638952255, -0.08321397006511688, -0.11044862121343613, -0.0203607939183712, 0.1201166957616806, -0.3189134895801544, 0.08570896834135056, 0.05015447363257408], "changes": {"1wk": -2.868321575494823}}, {"text": "LIVE The latest news and updates on Trump's tariffs Exploring High Growth Tech Stocks In January 2025 editorial-team@simplywallst.com (Simply Wall St) Fri, Jan 10, 2025, 9:06 PM 4 min read In This Article: ARBE ARBEW DV BCRX The United States market has remained flat over the past week but has shown a robust 23% increase over the past year, with earnings projected to grow by 15% annually. In this environment, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation and adaptability to capitalize on these favorable conditions. Top 10 High Growth Tech Companies In The United States Name Revenue Growth Earnings Growth Growth Rating Super Micro Computer 24.13% 24.28% \u2605\u2605\u2605\u2605\u2605\u2605 Ardelyx 22.86% 54.70% \u2605\u2605\u2605\u2605\u2605\u2605 AVITA Medical 33.76% 52.47% \u2605\u2605\u2605\u2605\u2605\u2605 Alkami Technology 21.99% 102.65% \u2605\u2605\u2605\u2605\u2605\u2605 Alnylam Pharmaceuticals 21.47% 56.38% \u2605\u2605\u2605\u2605\u2605\u2605 TG Therapeutics 30.33% 44.07% \u2605\u2605\u2605\u2605\u2605\u2605 Clene 61.16% 59.11% \u2605\u2605\u2605\u2605\u2605\u2605 Travere Therapeutics 28.68% 62.50% \u2605\u2605\u2605\u2605\u2605\u2605 Seagen 22.57% 71.80% \u2605\u2605\u2605\u2605\u2605\u2605 ImmunoGen 26.00% 45.85% \u2605\u2605\u2605\u2605\u2605\u2605 Click here to see the full list of 237 stocks from our US High Growth Tech and AI Stocks screener. Let's review some notable picks from our screened stocks. Arbe Robotics Simply Wall St Growth Rating: \u2605\u2605\u2605\u2605\u2605\u2606 Overview: Arbe Robotics Ltd. is a semiconductor company that offers 4D imaging radar solutions to tier 1 automotive suppliers and manufacturers across various countries, with a market cap of $290.93 million. Operations: Arbe Robotics generates revenue primarily from the Auto Parts & Accessories segment, amounting to $1.02 million. The company focuses on providing advanced radar solutions to automotive industry leaders in several key international markets. Arbe Robotics, amidst a flurry of activity, has demonstrated its commitment to innovation in the automotive safety sector through a strategic collaboration with NVIDIA. This partnership aims to enhance vehicle autonomy by integrating Arbe's high-resolution radar technology with NVIDIA's DRIVE AGX platform, promising advanced free space mapping and AI-driven capabilities. Despite recent financial struggles indicated by a net loss of $12.57 million in Q3 2024 and an overall challenging revenue trajectory, Arbe is positioning itself at the forefront of radar technology for autonomous driving systems. Their recent equity offerings and anticipated revenue growth suggest efforts to stabilize finances while pushing technological boundaries in ADAS applications and beyond. Click to explore a detailed breakdown of our findings in Arbe Robotics' health report. Assess Arbe Robotics' past performance with our detailed historical performance reports. NasdaqCM:ARBE Revenue and Expenses Breakdown as at Jan 2025 BioCryst Pharmaceuticals Simply Wall St Growth Rating: \u2605\u2605\u2605\u2605\u2606\u2606 Overview: BioCryst Pharmaceuticals, Inc. is a biotechnology company focused on developing oral small-molecule and protein therapeutics for the treatment of rare diseases, with a market cap of $1.67 billion. Story Continues Operations: BioCryst Pharmaceuticals generates revenue primarily from its biotechnology segment, particularly focusing on startups, with reported revenues of $412.58 million. The company is engaged in the development of therapeutics for rare diseases using oral small-molecule and protein technologies. BioCryst Pharmaceuticals is making significant strides in the biotech sector, particularly with its groundbreaking oral treatment, ORLADEYO, for hereditary angioedema. Recently recommended by Ireland's Health Services Executive and licensed in 44 countries, this innovation marks a pivotal shift towards accessible patient care. Financially, BioCryst has adjusted its 2024 revenue outlook to between $443 million and $448 million following robust ORLADEYO sales. Despite a historical net loss of $14.03 million in Q3 2024, the company's strategic focus on this novel treatment and anticipated profitability by 2026 reflect a resilient growth trajectory amidst market challenges. Dive into the specifics of BioCryst Pharmaceuticals here with our thorough health report. Gain insights into BioCryst Pharmaceuticals' historical performance by reviewing our past performance report. NasdaqGS:BCRX Earnings and Revenue Growth as at Jan 2025 DoubleVerify Holdings Simply Wall St Growth Rating: \u2605\u2605\u2605\u2605\u2606\u2606 Overview: DoubleVerify Holdings, Inc. offers a software platform focused on digital media measurement and data analytics services globally, with a market capitalization of approximately $3.38 billion. Operations: DoubleVerify Holdings, Inc. generates revenue primarily from its data processing services, totaling approximately $638.46 million. The company focuses on providing digital media measurement and analytics solutions internationally. DoubleVerify Holdings is carving a niche in the high-tech landscape with its focus on enhancing digital advertising quality through AI-driven solutions. In 2024, the company introduced groundbreaking tools like the Generative AI Website Avoidance & Detection solution, addressing the challenges posed by low-quality, AI-generated content which affects 54% of marketers. This innovation complements their robust financial performance with a notable third-quarter revenue of $169.56 million and net income growth to $18.2 million from $13.35 million year-over-year. Their strategic partnerships and proprietary technologies not only optimize ad performance but also ensure brand safety, positioning them favorably in a competitive market where precision and reliability are paramount. Take a closer look at DoubleVerify Holdings' potential here in our health report. Gain insights into DoubleVerify Holdings' past trends and performance with our Past report. NYSE:DV Earnings and Revenue Growth as at Jan 2025 Key Takeaways Reveal the 237 hidden gems among our US High Growth Tech and AI Stocks screener with a single click here. Already own these companies? Bring clarity to your investment decisions by linking up your portfolio with Simply Wall St , where you can monitor all the vital signs of your stocks effortlessly. Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world. Contemplating Other Strategies? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management . Find companies with promising cash flow potential yet trading below their fair value . This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NasdaqCM:ARBE NasdaqGS:BCRX and NYSE:DV . Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "BCRX", "date": "2025-01-10T21:06:59", "sentiment": {"score": 0.8270085481926799, "confidence": 0.8348442912101746, "probabilities": {"positive": 0.8348442912101746, "negative": 0.007835743017494678, "neutral": 0.15731997787952423}}, "embedding": [-0.06679727137088776, -0.1322873830795288, -0.034517399966716766, -0.07588218152523041, 0.011727223172783852, -0.10022957623004913, 0.022451698780059814, 0.06660108268260956, -0.04625454545021057, 0.05108315497636795, -0.11290981620550156, 0.08063818514347076, 0.07254108786582947, -0.06529265642166138, -0.04900362342596054, 0.029783355072140694, 0.05888544023036957, -0.10928603261709213, 0.0048210471868515015, -0.008735395967960358, -0.05190223455429077, -0.0283204298466444, -0.0061920154839754105, -0.13450776040554047, -0.0022938065230846405, 0.051067568361759186, 0.009186793118715286, -0.0803341269493103, -0.24716389179229736, -0.18584388494491577, 0.03533228486776352, 0.16470301151275635, 0.034446027129888535, -0.02400503307580948, -0.031685344874858856, -0.07435286045074463, -0.008474929258227348, 0.03620115667581558, -0.010025088675320148, -0.11563318222761154, -0.0307157002389431, -0.0007768319919705391, -0.07766218483448029, 0.027929190546274185, -0.015984412282705307, -0.054556120187044144, -0.0018054144456982613, -0.031588342040777206, 0.08751523494720459, -0.07372941821813583, -0.14297747611999512, -0.06304226070642471, 0.041616588830947876, 0.06268509477376938, -0.040528517216444016, 0.002691722009330988, -0.17158761620521545, -0.11015968024730682, 0.15978972613811493, -0.04771440476179123, 0.048406921327114105, -0.06996914744377136, 0.07109189033508301, -0.02930905669927597, 0.0648680180311203, -0.014330304227769375, -0.0289726871997118, 0.004241284914314747, -0.08102443814277649, -0.009764675050973892, 0.09503555297851562, 0.0345638133585453, -0.0791500136256218, 0.020493630319833755, -0.048955921083688736, 0.021999074146151543, 0.15689808130264282, 0.018525786697864532, 0.23133227229118347, -0.09953755140304565, -0.07559015601873398, 0.024354830384254456, -0.01046829205006361, 0.00943661853671074, -0.060385867953300476, -0.008544291369616985, 0.0269161444157362, 0.015151218511164188, 0.1291986107826233, -0.026878351345658302, 0.10342186689376831, -0.02591746300458908, -0.0872519314289093, 0.025696948170661926, 0.0023578424006700516, -0.040425416082143784, 0.017581360414624214, -0.10295834392309189, -0.01968195289373398, 0.0396650955080986, 0.14726093411445618, -0.06421269476413727, 0.022191204130649567, 0.05957097187638283, -0.08468066155910492, -0.08379366993904114, 0.09624025970697403, 0.06785671412944794, 0.07408837229013443, 0.02623337134718895, -0.07192428410053253, 0.06574587523937225, -0.16508004069328308, -0.050240494310855865, -0.13702020049095154, -0.02746957540512085, -0.07414180785417557, -0.03273814171552658, 0.06881920993328094, -0.0444820336997509, 0.05683394521474838, 0.0542621985077858, -0.11573522537946701, -0.06695529818534851, 0.02272447943687439, 0.01793571002781391, -0.1239403784275055, 1.6479230324922694e-32, -0.06861070543527603, 0.1276320219039917, -0.027487346902489662, -0.009330933913588524, -0.02824939787387848, 0.024611931294202805, 0.013945559039711952, 0.05212515592575073, -0.08151611685752869, -0.020030489191412926, -0.3131257891654968, 0.08494832366704941, -0.12470254302024841, 0.18897713720798492, 0.12293791025876999, -0.12084293365478516, -0.05703859403729439, 0.04548444598913193, 0.036608025431632996, -0.0228835791349411, 0.02876591682434082, 0.06039287522435188, -0.058345433324575424, 0.1261957585811615, 0.11024640500545502, 0.029655592516064644, -0.012305550277233124, -0.07472880184650421, -0.030574381351470947, 0.09649652242660522, -0.09291424602270126, 0.1020631194114685, -0.019688094034790993, -0.015520520508289337, -0.004232071340084076, -0.06117644160985947, -0.08149099349975586, -0.058513205498456955, 0.0060785748064517975, 0.07027620822191238, -0.023320429027080536, 0.061904095113277435, -0.20080748200416565, -0.06846080720424652, 0.036901190876960754, 0.007971635088324547, -0.023023830726742744, 0.01646164432168007, -0.0016033700667321682, 0.0033728238195180893, -0.08588242530822754, 0.07295443117618561, 0.020055945962667465, -0.12269356846809387, 0.050297461450099945, 0.07763643562793732, 0.01468624360859394, -0.054768480360507965, 0.14334720373153687, 0.04869924485683441, -0.05553906410932541, 0.07669772207736969, 0.048813335597515106, 0.09756381064653397, -0.10332176834344864, 0.1347842663526535, 0.1735508143901825, 0.07471105456352234, -0.027437500655651093, 0.1931411623954773, -0.017996253445744514, -0.024539250880479813, 0.17038029432296753, -0.08486223220825195, 0.1121615320444107, 0.06252199411392212, -0.08502304553985596, 0.04072693735361099, 0.03028416819870472, -0.0118052177131176, -0.13674800097942352, 0.023618878796696663, -0.0322810597717762, 0.016429826617240906, 0.09183382987976074, -0.051816314458847046, -0.02390420250594616, 0.059084780514240265, -0.08924594521522522, -0.023913415148854256, 0.01186918094754219, -0.051909949630498886, -0.0932304635643959, 0.07628709822893143, -0.07357995957136154, -1.6701203331292282e-32, 0.03000197932124138, 0.004446543753147125, 0.06384819746017456, -0.005151993595063686, -0.06887336075305939, 0.058447644114494324, 0.04932239651679993, 0.056087661534547806, -0.01634296402335167, -0.07508853822946548, -0.05173611268401146, 0.13795648515224457, -0.03892286866903305, 0.0740925669670105, 0.011878296732902527, -0.02383601851761341, -0.005941741168498993, -0.11009259521961212, -0.040493667125701904, -0.09057293832302094, 0.030467644333839417, 0.07083845883607864, -0.14002646505832672, 0.05108405277132988, 0.021015264093875885, 0.04330281913280487, -0.015646256506443024, 0.09427119791507721, 0.02983163669705391, -0.00536394165828824, -0.037428177893161774, -0.0116316769272089, -0.05177675560116768, 0.10413749516010284, 0.06457923352718353, 0.04194966331124306, 0.10086560994386673, -0.09639677405357361, -0.058209799230098724, -0.1560637652873993, 0.0999298244714737, -0.029028937220573425, 0.06959190219640732, 0.09679561853408813, 0.028985613957047462, -0.05213697999715805, 0.0912385955452919, -0.014362022280693054, 0.06656986474990845, -0.00516477320343256, 0.025208041071891785, -0.020031340420246124, 0.009257812052965164, 0.009794861078262329, -0.10103211551904678, -0.002272716723382473, 0.0025439253076910973, 0.058188293129205704, -0.11368469893932343, -0.008435246534645557, 0.0498926043510437, 0.06557686626911163, 0.10099642723798752, 0.026203740388154984, -0.036995574831962585, 0.03869523108005524, 0.10871648788452148, 0.03497210144996643, -0.06760463118553162, -0.08052180707454681, 0.07728279381990433, -0.019689030945301056, 0.042826056480407715, -0.08561498671770096, -0.05803936719894409, 0.14241741597652435, 0.026891430839896202, -0.06025480479001999, -0.06024277210235596, 0.025159379467368126, -0.014538351446390152, -0.03142036870121956, 0.024514850229024887, 0.09768019616603851, -0.1054147407412529, 0.10551020503044128, -0.05539379268884659, -0.10115641355514526, -0.033937033265829086, 0.02105768397450447, -0.12549421191215515, -0.09263253211975098, -0.11700040847063065, 0.019709572196006775, -0.12350761145353317, -1.012964787605597e-07, 0.018207821995019913, 0.05038170889019966, -0.012372546829283237, -0.08188953250646591, 0.1036660224199295, -0.05515684559941292, 0.011665025725960732, 0.09746798872947693, 0.05813601240515709, 0.07596360892057419, 0.10596132278442383, -0.06300008296966553, -0.060508280992507935, 0.046916600316762924, 0.03632890805602074, 0.03332189470529556, -0.07408061623573303, 0.03275120258331299, -0.04035831242799759, -0.11161711812019348, 0.039182014763355255, 0.13393378257751465, 0.126036137342453, -0.03450419008731842, 0.03410579636693001, -0.03590471297502518, -0.07012130320072174, -0.10777691006660461, 0.09848986566066742, 0.037697818130254745, -0.004869659431278706, -0.0012740567326545715, 0.0735238641500473, 0.031278595328330994, 0.13395918905735016, -0.11751648038625717, 0.03691558912396431, 0.00930175743997097, 0.1484672576189041, -0.006761655211448669, 0.04806831106543541, 0.04951789975166321, -0.03693009167909622, -0.05152461677789688, -0.06121892109513283, -0.06302624940872192, -0.21417441964149475, -0.08724178373813629, 0.052541546523571014, -0.13461986184120178, -0.01977316290140152, 0.0007426408119499683, -0.08687327057123184, 0.029622757807374, -0.011814657598733902, 0.16459646821022034, -0.04226384311914444, -0.14864592254161835, -0.032569676637649536, 0.03403869643807411, 0.11204563081264496, -0.1996898353099823, -0.020213089883327484, 0.2214558720588684], "changes": {"1wk": -2.868321575494823}}, {"text": "LIVE The latest news and updates on Trump's tariffs BioCryst price target raised to $12 from $10 at Evercore ISI TipRanks Tue, Jan 14, 2025, 4:35 PM 1 min read In This Article: BCRX https://www.tipranks.com/news/the-fly/warby-parker-price-target-raised-to-23-from-17-at-morgan-stanley Evercore ISI raised the firm\u2019s price target on BioCryst ( BCRX ) to $12 from $10 and keeps an Outperform rating on the shares. The company preannounced 2024 Orladeyo revenue of $437M, $2M ahead of the upper end of the guidance range and beating consensus by $4M, notes the analyst, who thinks 2025 guidance of $515-$535M for Orladeyo revenue is \u201cconservative\u201d when considering the 5% price increase and availability of funds to cover Medicare copay this year. Stay Ahead of the Market: Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener Published first on TheFly \u2013 the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today\u2019s best-performing stocks on TipRanks >> Read More on BCRX: BioCryst to Present at J.P. Morgan Conference Venu Sports JV discontinued, Walgreens reports Q1 beat: Morning Buzz BioCryst Projects Strong Revenue Growth in 2024-2025 BioCryst sees FY25 ORLADEYO revenue between $515M-$535M BioCryst reports Q4 preliminary revenue $130.8M, consensus $128.65M View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "BCRX", "date": "2025-01-14T16:35:49", "sentiment": {"score": 0.2625663848593831, "confidence": 0.27531859278678894, "probabilities": {"positive": 0.27531859278678894, "negative": 0.012752207927405834, "neutral": 0.7119291424751282}}, "embedding": [-0.09504339098930359, -0.07017916440963745, -0.09481317549943924, -0.050263166427612305, 0.12493046373128891, 0.03875172883272171, -0.04349910840392113, 0.15019650757312775, -0.06026506796479225, 0.05464109405875206, -0.03681695833802223, 0.09078680723905563, -0.055639613419771194, 0.009722299873828888, -0.06354300677776337, 0.04101311415433884, 0.08585628867149353, -0.06109338998794556, -0.08364038914442062, 0.0787758156657219, 0.02953409031033516, -0.1335982084274292, 0.05535363405942917, 0.034308772534132004, 0.096558578312397, -0.046433836221694946, -0.050299350172281265, -0.0377059169113636, -0.17634841799736023, -0.01602092944085598, -0.05302964895963669, 0.08738967031240463, -0.005157184321433306, -0.06432051956653595, -0.028698308393359184, -0.05557026341557503, 0.0458020456135273, 0.05564221739768982, 0.04182468727231026, 0.04486721754074097, -0.05670074746012688, -0.033624317497015, -0.2139137238264084, 0.01232846174389124, 0.006654730066657066, -0.1692700833082199, -0.012378854677081108, 0.08467112481594086, 0.09821154922246933, 0.05978899076581001, -0.2669644057750702, 0.014005600474774837, 0.037577614188194275, 0.005081730894744396, 0.05607025325298309, 0.08656715601682663, -0.08275876939296722, -0.07892480492591858, 0.07478988915681839, -0.03703737631440163, -0.03611860051751137, -0.15507012605667114, 0.08070965111255646, 0.01628042943775654, 0.06581950187683105, 0.007630884647369385, -0.12215372174978256, -0.019211431965231895, -0.06018294766545296, -0.0417904406785965, 0.11121866852045059, -0.09281815588474274, 0.007372839376330376, -0.04414843022823334, 0.020579710602760315, 0.1439550668001175, 0.1298137605190277, 0.13642321527004242, 0.14774978160858154, -0.06358928233385086, 0.0024802919942885637, -0.07922658324241638, -0.021577810868620872, -0.0584615096449852, -0.004140314180403948, -0.058229055255651474, 0.09127920866012573, 0.04739480838179588, 0.19238802790641785, 0.03816012293100357, 0.15338130295276642, -0.08689987659454346, -0.10262428969144821, -0.073826864361763, -0.02116849087178707, -0.022550204768776894, -0.08166810125112534, -0.10328478366136551, 0.061200328171253204, -0.027671609073877335, 0.08209256082773209, 0.0029747195076197386, -0.06826681643724442, -0.13611993193626404, -0.015920206904411316, -0.07340128719806671, 0.0913066565990448, 0.1192818358540535, 0.1169547364115715, 0.04224817082285881, -0.016456864774227142, 0.060994409024715424, -0.0007123305113054812, 0.011509916745126247, -0.15223534405231476, 0.07051083445549011, -0.07484006881713867, -0.053089264780282974, 0.18565236032009125, 0.04282678663730621, 0.029007144272327423, 0.10025431215763092, -0.050071630626916885, 0.1033157929778099, -0.07031966000795364, 0.07128021866083145, -0.2301499843597412, 1.557751595524661e-32, 0.023987120017409325, 0.09667892754077911, -0.019583720713853836, -0.11109238117933273, -0.14798302948474884, 0.08634457737207413, 0.06941797584295273, 0.016204798594117165, -0.08977951854467392, -0.10115140676498413, -0.1549120545387268, 0.039211612194776535, -0.07740528881549835, 0.01777498982846737, 0.03668680787086487, -0.26030460000038147, -0.05798475071787834, 0.057845085859298706, -0.0438355952501297, -0.023747041821479797, 0.07147405296564102, -0.006325878668576479, -0.06779811531305313, -0.04071589186787605, 0.12560002505779266, 0.08102183043956757, -0.08306321501731873, -0.10123667865991592, 0.022564047947525978, 0.09065832942724228, 0.02411683090031147, -0.02360222116112709, -0.06261967122554779, -0.13121271133422852, -0.016197366639971733, -0.0817769467830658, -0.0769837349653244, -0.04948743060231209, -0.041454214602708817, -0.007375392131507397, -0.07405359297990799, 0.17273618280887604, 0.014284717850387096, -0.07986923307180405, -0.036884382367134094, 0.019962891936302185, -0.06352958083152771, 0.12293112277984619, 0.0058863526210188866, -0.11343936622142792, -0.12514112889766693, -0.00664723664522171, -0.0062879533506929874, -0.052243705838918686, -0.06801030784845352, -0.029849771410226822, -0.004805907141417265, -0.15644891560077667, 0.02991017885506153, 0.05261806771159172, 0.050697389990091324, 0.11276928335428238, -0.029494378715753555, -0.08817190676927567, -0.15701328217983246, 0.17480306327342987, 0.009082802571356297, 0.10688269883394241, -0.10844102501869202, 0.17980970442295074, 0.11355596780776978, -0.023003172129392624, 0.169807568192482, 0.010677998885512352, 0.024286165833473206, 0.005009039770811796, -0.012212543748319149, 0.049770236015319824, 0.06624384969472885, -0.08053576201200485, 0.04142625629901886, -0.014551348984241486, 0.09051813185214996, 0.00878568273037672, 0.09633751213550568, -0.02105686254799366, 0.02150445245206356, -0.0033149761147797108, -0.05351339653134346, 0.016880547627806664, 0.019926467910408974, -0.04548801854252815, -0.027208929881453514, 0.07365234941244125, -0.10273027420043945, -1.339539436393735e-32, -0.06650389730930328, 0.0016019279137253761, 0.15715767443180084, 0.03839936479926109, -0.037165988236665726, 0.022025521844625473, 0.023132015019655228, -0.008926223032176495, 0.06906311959028244, -0.07112100720405579, -0.05506761744618416, 0.07775259763002396, -0.012183103710412979, 0.08130288124084473, -0.008632202632725239, 0.04565322771668434, -0.008884290233254433, -0.05818064883351326, -0.0022981958463788033, -0.11885558068752289, -0.03675209730863571, 0.10166383534669876, -0.14829851686954498, 0.18664902448654175, 0.05501648783683777, 0.11711757630109787, 0.04284099116921425, 0.11674275249242783, 0.01783902943134308, 0.015456527471542358, -0.11414036899805069, 0.008709104731678963, -0.1313249170780182, 0.043740712106227875, 0.03268413990736008, 0.14498481154441833, 0.010229654610157013, -0.08211308717727661, 0.010112152434885502, 0.07280881702899933, 0.08056086301803589, 0.00670407060533762, -0.028947915881872177, -0.0015943157486617565, 0.016700852662324905, 0.01670445315539837, -0.08940959721803665, 0.08261069655418396, 0.16716736555099487, 0.11695034056901932, -0.06202713027596474, 0.06940536946058273, 0.038244932889938354, 0.1329566240310669, -0.2017422914505005, -0.013270123861730099, -0.01635042205452919, 0.07045509666204453, -0.18797935545444489, -0.08195319771766663, 0.04423748329281807, 0.09468769282102585, -0.0022248353343456984, 0.03156924992799759, -0.017413895577192307, 0.04013550654053688, -0.020437179133296013, -0.08067166060209274, -0.04623959958553314, -0.12205412983894348, -0.08990154415369034, -0.09919580072164536, 0.1393880993127823, -0.07086563855409622, -0.09595870971679688, 0.22253766655921936, 0.009594577364623547, -0.10348367691040039, -0.03675072640180588, 0.06523080170154572, -0.012204427272081375, 0.0034836637787520885, 0.017632700502872467, 0.004426171537488699, 0.011659612879157066, 0.16132576763629913, 0.10878334194421768, 0.009585652500391006, -0.10482379049062729, 0.010851826518774033, -0.1086650863289833, -0.1379302591085434, -0.019132306799292564, 0.08343996852636337, 0.01404168177396059, -9.948148260718881e-08, 0.051886186003685, -0.03820369020104408, 0.035950928926467896, 0.04428933560848236, 0.11852806061506271, -0.05872702598571777, 0.027572426944971085, 0.026964396238327026, 0.05273070186376572, 0.08122668415307999, 0.14597706496715546, 0.09571868181228638, -0.15648120641708374, 0.007766523398458958, 0.006693596951663494, -0.05842641368508339, -0.07086330652236938, 0.01618209481239319, -0.05127736181020737, -0.08709775656461716, -0.007562497165054083, 0.09560400247573853, 0.018420418724417686, -0.024006081745028496, 0.05620625242590904, 0.012586967088282108, 0.012085874564945698, 0.02982916124165058, 0.11744184046983719, 0.06075889989733696, 0.008273033425211906, -0.0374794565141201, 0.005391301587224007, 0.010202533565461636, 0.03289869427680969, 0.043586187064647675, -0.0550219863653183, 0.09345681220293045, 0.07655928283929825, 0.13760322332382202, 0.02095077559351921, -0.05847793444991112, -0.03692168369889259, -0.012015152722597122, 0.04314247891306877, -0.08819727599620819, -0.16167853772640228, 0.02763182297348976, 0.057036250829696655, -0.14727771282196045, 0.017247669398784637, 0.013664360158145428, -0.015009700320661068, -0.00556023046374321, 0.07561331987380981, 0.041573114693164825, -0.16071204841136932, -0.000430512911407277, -0.12658360600471497, 0.06908293813467026, 0.1218286082148552, -0.26784855127334595, 0.05614083260297775, 0.12114042043685913], "changes": {"1wk": 3.042873991857099}}, {"text": "LIVE The latest news and updates on Trump's tariffs BioCryst to Present at 43rd Annual J.P. Morgan Healthcare Conference BioCryst Pharmaceuticals, Inc. Tue, Jan 7, 2025, 3:00 PM 1 min read In This Article: BCRX BioCryst Pharmaceuticals, Inc. RESEARCH TRIANGLE PARK, N.C., Jan. 07, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 14, 2025, at 6:00 p.m. ET. Link to the live audio webcast and replay of the presentation may be accessed in the Investors & Media section of BioCryst\u2019s website at www.biocryst.com . About BioCryst Pharmaceuticals BioCryst Pharmaceuticals is a global biotechnology company with a deep commitment to improving the lives of people living with hereditary angioedema and other rare diseases. BioCryst leverages its expertise in structure-guided drug design to develop first-in-class or best-in-class oral small-molecule and protein therapeutics to target difficult-to-treat diseases. BioCryst has commercialized ORLADEYO \u00ae (berotralstat), the first oral, once-daily plasma kallikrein inhibitor, and is advancing a pipeline of small-molecule and protein therapies. For more information, please visit www.biocryst.com or follow us on LinkedIn . BCRXW Contact: John Bluth +1 919 859 7910 jbluth@biocryst.com View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "BCRX", "date": "2025-01-07T15:00:00", "sentiment": {"score": 0.07280459627509117, "confidence": 0.08312507718801498, "probabilities": {"positive": 0.08312507718801498, "negative": 0.010320480912923813, "neutral": 0.9065544009208679}}, "embedding": [-0.1414424329996109, -0.06577145308256149, -0.07342496514320374, -0.11102429777383804, 0.08298816531896591, -0.02901267446577549, -0.11376684159040451, 0.25324276089668274, 0.07187867909669876, -0.016841428354382515, -0.11569038033485413, 0.07146649062633514, -0.0031328503973782063, 0.12269014120101929, -0.10165367275476456, 0.01742120459675789, -0.014723562635481358, 0.004802974406629801, -0.04989781230688095, 0.12334683537483215, 0.05868813022971153, 0.045115940272808075, 0.018793433904647827, 0.12124332040548325, -0.0301629900932312, 0.09134010970592499, -0.029816191643476486, -0.09269294142723083, -0.17291611433029175, -0.009170763194561005, -0.019626397639513016, 0.05994333699345589, 0.11301524937152863, -0.06948839873075485, 0.04935064539313316, 0.07332679629325867, -0.10680912435054779, 0.035041116178035736, -0.023913094773888588, -0.00735545763745904, -0.04280446469783783, -0.1307191401720047, -0.11825402826070786, -0.013453771360218525, 0.052029360085725784, -0.12877257168293, 0.007998720742762089, 0.003589128376916051, 0.07695174217224121, 0.13211168348789215, -0.19244973361492157, -0.056996867060661316, 0.015777936205267906, 0.05865666642785072, 0.013499167747795582, -0.035157710313797, -0.19023030996322632, -0.07180318236351013, 0.036956313997507095, -0.0631365180015564, 0.01825685240328312, -0.1327245831489563, 0.036658190190792084, 0.07293391972780228, 0.030870603397488594, 0.0014500959077849984, -0.027883317321538925, -0.03324218466877937, 0.0022526858374476433, -0.07371410727500916, 0.057506173849105835, -0.06626096367835999, 0.03775547817349434, 0.23417918384075165, 0.009291229769587517, 0.09396779537200928, 0.13382187485694885, 0.14022065699100494, 0.08921719342470169, -0.05714331567287445, 0.13192884624004364, 0.015318079851567745, -0.029524540528655052, 0.03868211433291435, 0.005182921886444092, 0.0366651751101017, 0.00012625675299204886, 0.08553998172283173, 0.06686809659004211, -0.028320400044322014, 0.1594436913728714, 0.06402669101953506, -0.0020270557142794132, -0.005373936612159014, -0.11458691954612732, -0.0983620211482048, -0.022736266255378723, 0.0629325732588768, 0.05031708627939224, -0.01935451105237007, -0.04891480505466461, -0.0022633634507656097, -0.04504699632525444, -0.026293793693184853, -0.09346408396959305, -0.1170826107263565, -0.010429405607283115, 0.039640504866838455, 0.11164591461420059, 0.0666288509964943, -0.07973718643188477, 0.06542859226465225, 0.008355614729225636, 0.017549797892570496, -0.0850018560886383, 0.16633594036102295, 0.00022606219863519073, -0.0529358871281147, 0.17317460477352142, 0.03241194412112236, 0.003594132838770747, -0.01821368932723999, -0.0446111336350441, -0.08214282989501953, 0.010129881091415882, 0.06341007351875305, -0.1436907947063446, 8.644718433745539e-33, -0.010378542356193066, 0.05669621750712395, 0.05913937836885452, 0.11473032832145691, -0.05027271434664726, 0.020212000235915184, 0.007892115041613579, -0.08166994899511337, -0.1565275341272354, -0.12776358425617218, -0.11022227257490158, -0.03531398996710777, 0.034735970199108124, 0.15762916207313538, -0.06469929218292236, -0.15804874897003174, -0.06462091207504272, -0.04277590662240982, -0.000862455228343606, -0.007436712738126516, 0.05624763295054436, 0.11702995002269745, -0.04260376840829849, 0.1275559663772583, -0.019953696057200432, 0.04860874265432358, -0.002686720807105303, -0.0523868128657341, 0.13286864757537842, 0.07758278399705887, -0.12534359097480774, 0.02637123316526413, -0.05917387455701828, -0.16021236777305603, -0.015565088950097561, 0.029528381302952766, -0.05837901309132576, -0.13761575520038605, -0.033219244331121445, 0.028491146862506866, -0.11724800616502762, 0.04458558186888695, -0.14870567619800568, 0.022644080221652985, 0.05860898643732071, -0.07008596509695053, -0.060148466378450394, 0.11566085368394852, 0.0033897000830620527, -0.08559088408946991, -0.05117179453372955, 0.015013383701443672, 0.014498087577521801, -0.03044862113893032, 0.02462908625602722, 0.011315799318253994, -0.16371643543243408, -0.19625318050384521, 0.018562328070402145, 0.10768074542284012, 0.04497507959604263, 0.1173870712518692, -0.051206499338150024, 0.00892565306276083, -0.11994890123605728, 0.02431909367442131, -0.06564773619174957, -0.012679876759648323, -0.12601546943187714, 0.05522974580526352, 0.05379168689250946, 0.002246218267828226, 0.16283929347991943, 0.031046677380800247, 0.02619878202676773, 0.037310633808374405, 0.06491248309612274, 0.1566586047410965, -0.011359784752130508, 0.005996864289045334, -0.0390835665166378, -0.0250210203230381, 0.031949352473020554, 0.14733383059501648, -0.07723108679056168, -0.03714067116379738, 0.06481292843818665, -0.10269828140735626, -0.083551324903965, 0.054485984146595, -0.007101780269294977, -0.16417734324932098, -0.05525941029191017, 0.15804997086524963, -0.10889960080385208, -1.067558475883068e-32, 0.07256454974412918, -0.022878654301166534, 0.12534546852111816, 0.006358254235237837, -0.06074985861778259, 0.09626255184412003, 0.06475303322076797, -0.03514514118432999, 0.23469401895999908, -0.0847310870885849, 0.028676027432084084, 0.11155350506305695, 0.07017979770898819, 0.01846698857843876, -0.015252918936312199, 0.09873722493648529, -0.04267672076821327, -0.06672578305006027, -0.1355767399072647, 0.04551342502236366, 0.005571871530264616, 0.18144045770168304, -0.09898007661104202, 0.03901972994208336, 0.01249187532812357, 0.09801862388849258, -0.04593975469470024, 0.12483981251716614, 0.03093857876956463, -0.011726300232112408, -0.08284634351730347, 0.011198666878044605, -0.2429017573595047, -0.036933332681655884, -0.0415201261639595, 0.1486266702413559, -0.005202420987188816, -0.1372201293706894, 0.10268720239400864, -0.06696165353059769, 0.041747160255908966, -0.013527682051062584, -0.1456722617149353, 0.004905729554593563, 0.08506729453802109, -0.006579489912837744, -0.035555869340896606, 0.0968216210603714, 0.1343994140625, -0.013052894733846188, -0.08278017491102219, 0.11906187236309052, 0.05253879725933075, 0.01711677946150303, -0.05120956897735596, -0.0310759786516428, -0.015509815886616707, 0.013094588182866573, -0.10087250918149948, 0.010225986130535603, -0.003972392529249191, -0.02235272340476513, 0.010849281214177608, -0.004096768796443939, -0.009828000329434872, 0.03848554566502571, 0.07720989733934402, -0.050161030143499374, 0.0784948468208313, -0.08218506723642349, 0.011359361000359058, -0.030282018706202507, 0.09006528556346893, -0.01618051715195179, 0.09351184964179993, 0.07735194265842438, -0.12807925045490265, -0.11232060939073563, -0.1743279993534088, 0.04183419793844223, 0.05893607810139656, 0.03575411066412926, 0.03380686789751053, -0.022576145827770233, 0.050138942897319794, 0.11694920063018799, 0.08308395743370056, -0.049784667789936066, -0.06326261162757874, -0.04850700870156288, -0.14104998111724854, -0.11784295737743378, -0.07146615535020828, 0.17420558631420135, 0.06615104526281357, -1.0003479644637991e-07, 0.15760064125061035, -0.061156608164310455, -0.015637021511793137, -0.1632319688796997, -0.03773150593042374, -0.1034431904554367, -0.028312288224697113, -0.014346130192279816, 0.005574636161327362, 0.11167245358228683, 0.05225947126746178, 0.14742758870124817, -0.11063308268785477, -0.002249757759273052, -0.029119454324245453, 0.025554761290550232, -0.03698642924427986, -0.021242769435048103, -0.06901649385690689, -0.07758177816867828, -0.08482658118009567, 0.029186401516199112, 0.03495151549577713, -0.015970708802342415, 0.08810602128505707, -0.0874394103884697, 0.06237670034170151, -0.046875085681676865, 0.002484561875462532, -0.01890154927968979, -0.056658532470464706, 0.0052610114216804504, 0.03977130725979805, 0.09840264916419983, -0.022384490817785263, -0.12282116711139679, -0.09728579223155975, 0.055039260536432266, 0.05899496003985405, 0.0834074541926384, -0.005620044190436602, -0.0768641009926796, -0.08685029298067093, 0.07812383770942688, -0.011714189313352108, -0.03972120210528374, -0.15217527747154236, 0.07720471918582916, 0.04415804147720337, -0.04550830274820328, -0.06238381564617157, 0.010585873387753963, -0.01702377013862133, -0.07213202118873596, -0.0016427509253844619, 0.1390853077173233, -0.09511358290910721, -0.058601684868335724, 0.04261040315032005, -0.062134817242622375, 0.005406629294157028, -0.13600443303585052, 0.13025926053524017, 0.059711918234825134], "changes": {"1wk": -2.5798587976276237}}, {"text": "LIVE The latest news and updates on Trump's tariffs BioCryst Announces Preliminary Full Year 2024 ORLADEYO\u00ae (berotralstat) Net Revenue of $437 Million (+34 percent y-o-y) BioCryst Pharmaceuticals, Inc. Fri, Jan 10, 2025, 3:00 PM 8 min read In This Article: BCRX BioCryst Pharmaceuticals, Inc. \u2014ORLADEYO net revenue expected to be between $515-$535 million in 2025\u2014 \u2014Total revenue (including RAPIVAB \u00ae ) expected to be between $540-$560 million in 2025\u2014 \u2014Company achieved operating profit in 2024 (not including stock-based compensation) and expects to approach quarterly EPS profitability/positive cash flow in 2H 2025\u2014 \u2014New drug application planned in 2025 for ORLADEYO granules in children up to age 12; will address significant unmet need\u2014 \u2014Pipeline advancing into patients with Netherton syndrome (BCX17725) and diabetic macular edema (avoralstat) in 2025\u2014 RESEARCH TRIANGLE PARK, N.C., Jan. 10, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced preliminary, unaudited ORLADEYO \u00ae (berotralstat) net revenue and total revenue for the fourth quarter and full year 2024. The company also provided guidance for full year 2025 ORLADEYO net revenue and total revenue, full year 2025 operating expenses, and its expectation that the company will approach quarterly\u00a0earnings per share (EPS) profitability in the second half of 2025. \u201c2024 was a year of outstanding execution for the company on multiple fronts and it is exciting to carry this momentum into 2025. We had another year of exceptional ORLADEYO revenue growth moving us significantly closer to peak sales of $1 billion, and we did this while driving the company toward profitability in the near-term. We are excited that this year we expect to submit a new drug application to expand the ORLADEYO label to children under age 12 and to be in patient studies in two new clinical programs (BCX17725 and avoralstat),\u201d said Jon Stonehouse, president and chief executive officer of BioCryst. Preliminary Fourth Quarter and Full Year 2024 ORLADEYO Revenue and Total Revenue, and 2025 ORLADEYO and Total Revenue Outlook Preliminary, unaudited ORLADEYO net revenue in the fourth quarter of 2024 was $123.5 million (+36 percent y-o-y). Preliminary, unaudited ORLADEYO net revenue for full year 2024 was $437 million (+34 percent y-o-y). The company expects full year 2025 global net ORLADEYO revenue will be between $515 million and $535 million. \u201cORLADEYO revenue accelerated in 2024, with 34 percent annual growth in the fourth year on the market, compared to 30 percent in 2023. Over 1,200 U.S. physicians have prescribed ORLADEYO, and thousands of patients have benefitted in over 30 countries worldwide as physicians and patients continue to gain confidence in the exceptional efficacy and convenience that are possible with ORLADEYO. As we head into 2025, oral, preventative therapy with ORLADEYO is the new benchmark for HAE, and we are excited to soon bring this new option to children under age 12,\u201d said Charlie Gayer, chief commercial officer of BioCryst. Story Continues Preliminary, unaudited total revenue in the fourth quarter of 2024 was $130.8 million (+40 percent y-o-y). Preliminary, unaudited total revenue for full year 2024 was $450 million (+36 percent y-o-y). The company expects full year 2025 total revenue (including RAPIVAB \u00ae (peramivir injection)) will be between $540 million and $560 million. Operating Expense Outlook The company expects full year 2025 GAAP operating expenses to be between $485 million and $495 million. This includes an estimated $60 million related to stock-based compensation, therefore operating expenses not including stock-based compensation are forecasted at between $425 million and $435 million for the year. This operating expense outlook includes additional commercial investment to support the launch of the company\u2019s pediatric product in HAE, ongoing work on the transition study (APeX-T), and continued generation of real-world evidence to support and enhance the company\u2019s global commercial activities. For R&D, the additional investments include support for clinical activities for both BCX17725 and avoralstat. Profitability Outlook In 2024, revenue growth significantly exceeded operating expense growth. The company expects this pattern to continue, and over the next three years the company expects an annual CAGR for revenue of around 20 percent, compared to a projected annual operating expense CAGR of closer to five percent over the same period. Building on its significant operating profit in 2024 (not including stock-based compensation), the company expects to approach quarterly positive EPS and positive cash flow in the second half of 2025, and to be profitable on an EPS basis, with positive cash flow, for full year 2026. Presentation Tuesday at 43 r d Annual J.P. Morgan Healthcare Conference On Tuesday, January 14, 2025 at 6:00 p.m. ET, the company will present at the 43 r d Annual J.P. Morgan Healthcare Conference in San Francisco. Links to a live audio webcast and replay of the presentation may be accessed in the Investors section of BioCryst\u2019s website at www.biocryst.com . About BioCryst Pharmaceuticals BioCryst Pharmaceuticals is a global biotechnology company with a deep commitment to improving the lives of people living with hereditary angioedema and other rare diseases. BioCryst leverages its expertise in structure-guided drug design to develop first-in-class or best-in-class oral small-molecule and protein therapeutics to target difficult-to-treat diseases. BioCryst has commercialized ORLADEYO \u00ae (berotralstat), the first oral, once-daily plasma kallikrein inhibitor, and is advancing a pipeline of small-molecule and protein therapies. For more information, please visit www.biocryst.com or follow us on LinkedIn . Non-GAAP Financial Measures The information furnished in this release includes non-GAAP financial measures that differ from measures calculated in accordance with generally accepted accounting principles in the United States of America (GAAP). In particular, we provide the non-GAAP financial measure of expected full year 2025 GAAP operating expense, adjusted to show the expected results without including our estimated stock-based compensation expense. We believe providing this non-GAAP measure, which shows our expectations with this item adjusted, is valuable and useful since it allows management and investors to better understand the company\u2019s expected financial performance in the absence of certain non-cash items, such as stock-based compensation, and allows investors to more accurately understand our expectations and compare them to future results. This non-GAAP measure also corresponds with the way we expect Wall Street analysts to compare our results. Non-GAAP measures should be considered only as supplements to, and not as substitutes for or in isolation from, our other measures of financial information prepared in accordance with GAAP, such as GAAP revenue, operating income, net income and earnings per share. Forward-Looking Statements This press release contains forward-looking statements, including statements regarding preliminary, unaudited revenue results and future results, performance or achievements. These statements involve known and unknown risks, uncertainties and other factors which may cause BioCryst\u2019s actual results, performance or achievements to be materially different from any preliminary, unaudited revenue results and future results, performance or achievements expressed or implied by the forward-looking statements. These statements reflect our current views with respect to future events and are based on assumptions and are subject to risks and uncertainties. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Some of the factors that could affect the forward-looking statements contained herein include: BioCryst\u2019s completion of its customary closing, review and audit procedures for the fourth quarter and full year 2024, which may cause actual revenue results for these periods to differ materially from the preliminary, unaudited revenue results; BioCryst\u2019s ability to successfully implement or maintain its commercialization plans for ORLADEYO; BioCryst\u2019s ability to successfully progress its pipeline development plans as described herein; the results of BioCryst\u2019s partnerships with third parties may not meet BioCryst\u2019s current expectations; risks related to government actions, including that decisions and other actions, including as they relate to pricing, may not be taken when expected or at all, or that the outcomes of such decisions and other actions may not be in line with BioCryst\u2019s current expectations; the commercial viability of ORLADEYO, including its ability to achieve sustained market acceptance and demand; ongoing and future preclinical and clinical development of product candidates may take longer than expected and may not have positive results; BioCryst may not be able to enroll the required number of subjects in planned clinical trials of product candidates; BioCryst may not advance human clinical trials with product candidates as expected; the FDA or other applicable regulatory agency may require additional studies beyond the studies planned for products and product candidates, may not provide regulatory clearances which may result in delay of planned clinical trials, may impose certain restrictions, warnings, or other requirements on products and product candidates, may impose a clinical hold with respect to product candidates, or may withhold, delay or withdraw market approval for products and product candidates; product candidates, if approved, may not achieve market acceptance; BioCryst\u2019s ability to successfully commercialize its products and product candidates; BioCryst\u2019s ability to successfully manage its growth and compete effectively; risks related to the international expansion of BioCryst\u2019s business; timing for achieving and sustainability of profitability and positive cash flow may not meet management\u2019s expectations; statements and projections regarding financial guidance and goals and the attainment of such goals may differ from actual results based on market factors and BioCryst\u2019s ability to execute its operational and budget plans; and actual financial results may not be consistent with expectations, including that revenue, operating expenses and cash usage may not be within management\u2019s expected ranges. Please refer to the documents BioCryst files periodically with the Securities and Exchange Commission, specifically BioCryst\u2019s most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K, which identify important factors that could cause actual results to differ materially from those contained in BioCryst\u2019s projections and forward-looking statements. BCRXW Contact : John Bluth +1 919 859 7910 jbluth@biocryst.com View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "BCRX", "date": "2025-01-10T15:00:00", "sentiment": {"score": 0.8390847761183977, "confidence": 0.8492521047592163, "probabilities": {"positive": 0.8492521047592163, "negative": 0.010167328640818596, "neutral": 0.14058062434196472}}, "embedding": [-0.10780808329582214, -0.0023297411389648914, -0.013818587176501751, -0.16078254580497742, -0.09186403453350067, -0.0707465261220932, -0.10981268435716629, 0.24757859110832214, 0.01988595724105835, 0.04576487839221954, -0.008159684017300606, 0.029138101264834404, -0.0015600462211295962, 0.04120508208870888, -0.12187442183494568, 0.07748529314994812, 0.03778928890824318, -0.03714428469538689, -0.06009240075945854, 0.09777472913265228, 0.1964152455329895, -0.0006234124302864075, 0.01428261213004589, -0.010111358016729355, 0.0056395623832941055, 0.05800606310367584, -0.06690865755081177, -0.02818821370601654, -0.14285381138324738, -0.03401106595993042, 0.013478578068315983, 0.07878050953149796, 0.061639755964279175, -0.052244849503040314, 0.04285158962011337, 0.013130761682987213, -0.06925243139266968, 0.09879899024963379, -0.09666217863559723, 0.05209590122103691, -0.10062891244888306, -0.05067015811800957, -0.186836376786232, 0.07431627810001373, 0.0016117972554638982, -0.23065459728240967, -0.025836780667304993, 0.018686387687921524, 0.09183479845523834, 0.14481085538864136, -0.1601053774356842, -0.09711000323295593, 0.08980590850114822, 0.12458711862564087, 0.021951820701360703, 0.040675610303878784, -0.15198451280593872, -0.14846819639205933, -0.0672362893819809, 0.001365726813673973, -0.09291613101959229, -0.055738482624292374, -0.008592439815402031, 0.039538539946079254, 0.08943244814872742, 0.050312887877225876, -0.03646477311849594, -0.12018218636512756, -0.10703101754188538, -0.015558200888335705, 0.08723228424787521, -0.12702155113220215, 0.02421870082616806, 0.06255471706390381, -0.02284875139594078, 0.15879273414611816, 0.1762286275625229, 0.17106544971466064, 0.1563410758972168, -0.20977425575256348, 0.07869143784046173, 0.06826389580965042, -0.03583633899688721, -0.1064755767583847, -0.031073691323399544, 0.02153599262237549, 0.0777292400598526, 0.14581939578056335, 0.08913382887840271, 0.02335984632372856, 0.1574769914150238, -0.042380400002002716, -0.022878358140587807, -0.10828804969787598, -0.08010958135128021, -0.07691863179206848, -0.0669456273317337, -0.12419090420007706, 0.07763421535491943, -0.010739427991211414, 0.017060350626707077, -0.04627767205238342, -0.05234230309724808, -0.16275236010551453, -0.09584534913301468, -0.08416680991649628, 0.1227196678519249, 0.020171578973531723, 0.04250235855579376, 0.0299222469329834, -0.07267758250236511, 0.04775945097208023, 0.05450784042477608, 0.06514063477516174, -0.1329135000705719, 0.1647416055202484, -0.09038609266281128, -0.0023717181757092476, 0.2375098168849945, -0.0565243698656559, 0.09684969484806061, 0.0704861432313919, -0.04406331479549408, 0.019040793180465698, -0.07226375490427017, 0.012868547812104225, -0.10310670733451843, 1.350728232435243e-32, -0.05466577410697937, -0.01333136297762394, -0.00979140866547823, 0.034735698252916336, -0.05234462395310402, 0.14012669026851654, 0.0934428721666336, 0.026155833154916763, -0.05149098113179207, -0.17994087934494019, -0.20561349391937256, 0.0035156719386577606, -0.02266363799571991, 0.05074390769004822, -0.002303405897691846, -0.15018635988235474, -0.011900675483047962, 0.08701906353235245, 0.02387562021613121, 0.010591613128781319, 0.039674270898103714, 0.014496782794594765, -0.01965794526040554, 0.11575175076723099, 0.02289307862520218, 0.1427529752254486, -0.07787148654460907, -0.053220607340335846, 0.07126957923173904, 0.039075061678886414, 0.03686662018299103, 0.06395648419857025, -0.033349595963954926, -0.17269758880138397, -0.11199796199798584, -0.0759301707148552, 0.02599397487938404, -0.038379471749067307, 0.056983377784490585, 0.09858866035938263, -0.09368588775396347, 0.10421891510486603, -0.05692286044359207, -0.0685480535030365, -0.011978737078607082, -0.08448952436447144, 0.006040307693183422, 0.13956524431705475, 0.0320417694747448, -0.02510502003133297, -0.058646880090236664, -0.0056527722626924515, -0.068531334400177, -0.10947620868682861, -0.05132986232638359, 0.02654670923948288, -0.13795576989650726, -0.13491910696029663, 0.07541105151176453, 0.06808945536613464, 0.11824816465377808, 0.1364220678806305, 0.039042383432388306, -0.10005627572536469, -0.11650451272726059, 0.09602706134319305, 0.04377429559826851, 0.005387365818023682, -0.05403763800859451, 0.0652427226305008, 0.0077202352695167065, -0.08801385015249252, 0.1258152723312378, -0.015769848600029945, 0.10505931079387665, -0.018465176224708557, 0.045269615948200226, 0.04088026285171509, 0.019454875960946083, 0.013251535594463348, -0.03095308691263199, 0.04705832898616791, 0.046794064342975616, 0.03132520243525505, 0.07842526584863663, 0.024811644107103348, 0.0655626431107521, 0.03377602994441986, -0.16766002774238586, 0.06871207058429718, 0.05154561251401901, -0.04215404391288757, -0.10280920565128326, 0.18219870328903198, -0.004009798169136047, -1.434502188335295e-32, -0.02607332542538643, 0.03009984642267227, 0.06823495030403137, -0.12533307075500488, -0.027543069794774055, 0.04549945890903473, 0.06339690089225769, 0.03272786736488342, 0.0897076353430748, -0.13827544450759888, -0.04391881078481674, 0.10743708908557892, 0.029668515548110008, 0.009251165203750134, -0.044890083372592926, 0.05540776252746582, -0.046352703124284744, -0.008076171390712261, -0.09909115731716156, -0.0024513481184840202, 0.01647469401359558, 0.24682065844535828, -0.1540212780237198, 0.13993340730667114, 0.09898361563682556, 0.12021437287330627, 0.037134427577257156, 0.13426226377487183, 0.015261732041835785, 0.02273382619023323, -0.11373616755008698, 0.0035625165328383446, -0.2562098205089569, -0.01462352555245161, 0.044615551829338074, 0.031790412962436676, 0.025043491274118423, -0.17056146264076233, -0.03228272497653961, -0.03509160876274109, 0.0637294128537178, -0.008883431553840637, -0.041253868490457535, 0.011150256730616093, 0.03888540342450142, -0.09635214507579803, -0.005864000413566828, 0.00204293429851532, 0.16972824931144714, 0.059151265770196915, -0.031447671353816986, 0.047617144882678986, -0.021879807114601135, 0.06259416043758392, -0.13695615530014038, 0.03085402026772499, 0.01741279475390911, -0.07775619626045227, -0.06935159862041473, -0.08484040200710297, 0.020190855488181114, 0.023812051862478256, -0.009415722452104092, -0.03264772146940231, 0.024132879450917244, 0.11865302175283432, 0.07553109526634216, -0.1327986866235733, 0.06557318568229675, -0.12383484095335007, -0.07176318764686584, -0.08359278738498688, 0.00589401088654995, -0.15007981657981873, 0.008235961198806763, 0.15673291683197021, 0.05386557802557945, -0.17659945785999298, -0.11410100758075714, -0.007344510406255722, -0.06293761730194092, 0.017997952178120613, 0.03483019396662712, 0.0293650534003973, -0.0631057471036911, 0.000831305980682373, 0.0979529470205307, -0.0952225774526596, -0.07549558579921722, 0.07234099507331848, -0.09061922878026962, -0.09880281239748001, -0.10093728452920914, 0.13538607954978943, 0.13782262802124023, -1.0066672473385552e-07, 0.1531296670436859, 0.004376351833343506, 0.037421245127916336, -0.026319555938243866, 0.12184402346611023, -0.1547865867614746, -0.038907308131456375, 0.016499247401952744, 0.09785452485084534, 0.047121331095695496, 0.04977799206972122, 0.20193201303482056, -0.09847453236579895, 0.006303713656961918, -0.04113709181547165, 0.05408266559243202, -0.040783610194921494, 0.09149399399757385, -0.04236719384789467, -0.08192209899425507, -0.1309419572353363, 0.001745374407619238, 0.004698461852967739, -0.04342522472143173, 0.03210953250527382, -0.12087784707546234, 0.0766572579741478, 0.039007943123579025, -0.034465812146663666, 0.0017085503786802292, 0.06411188095808029, -0.01998627558350563, 0.0431772880256176, 0.0442880280315876, -0.0034443484619259834, -0.15088647603988647, -0.08075927197933197, 0.1730954647064209, 0.08560065925121307, 0.05909516662359238, -0.014668101444840431, -0.05195264518260956, 0.005858306773006916, 0.05073368549346924, 0.016064109280705452, -0.14361707866191864, -0.22862079739570618, 0.017111990600824356, 0.09887288510799408, -0.10059433430433273, 0.027693727985024452, -0.03320708125829697, 0.021817903965711594, -0.09371678531169891, 0.06714837998151779, 0.03872329741716385, -0.0874996930360794, -0.07710277289152145, -0.0887756496667862, 0.09376298636198044, 0.0697927251458168, -0.1901998519897461, 0.1449342519044876, -0.014821898192167282], "changes": {"1wk": -7.953065546893049}}, {"text": "LIVE The latest news and updates on Trump's tariffs BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) BioCryst Pharmaceuticals, Inc. Mon, Jan 6, 2025, 3:00 PM 2 min read In This Article: BCRX BioCryst Pharmaceuticals, Inc. RESEARCH TRIANGLE PARK, N.C., Jan. 06, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst\u2019s board of directors granted 10 newly-hired employees stock options to purchase an aggregate of 52,750 shares, and restricted stock units (RSUs) covering an aggregate of 36,975 shares, of BioCryst common stock. The options and RSUs were granted as of December 31, 2024, as inducements material to each employee entering into employment with BioCryst. The options and RSUs were granted in accordance with Nasdaq Listing Rule 5635(c)(4). The options have an exercise price of $7.52 per share, which is equal to the closing price of BioCryst common stock on the grant date. The options and RSUs vest in four equal annual installments beginning on the one-year anniversary of the grant date, in each case subject to the new employee\u2019s continued service with the company. Each stock option has a 10-year term. The options and RSUs are subject to the terms and conditions of BioCryst\u2019s Inducement Equity Incentive Plan and a stock option agreement or restricted stock unit agreement, as applicable, covering the grant. About BioCryst Pharmaceuticals BioCryst Pharmaceuticals is a global biotechnology company with a deep commitment to improving the lives of people living with hereditary angioedema and other rare diseases. BioCryst leverages its expertise in structure-guided drug design to develop first-in-class or best-in-class oral small-molecule and protein therapeutics to target difficult-to-treat diseases. BioCryst has commercialized ORLADEYO \u00ae (berotralstat), the first oral, once-daily plasma kallikrein inhibitor, and is advancing a pipeline of small-molecule and protein therapies. For more information, please visit www.biocryst.com or follow us on LinkedIn . BCRXW Contact: John Bluth +1 919 859 7910 jbluth@biocryst.com View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "BCRX", "date": "2025-01-06T15:00:00", "sentiment": {"score": 0.11539854109287262, "confidence": 0.12386825680732727, "probabilities": {"positive": 0.12386825680732727, "negative": 0.008469715714454651, "neutral": 0.8676620721817017}}, "embedding": [-0.09128143638372421, -0.01450407411903143, -0.0468292310833931, -0.13050127029418945, -0.047376058995723724, 0.026288501918315887, -0.07307583838701248, 0.24580712616443634, 0.11419534683227539, 0.041190315037965775, -0.05984093248844147, 0.05811981111764908, 0.020851556211709976, 0.12645526230335236, -0.07495276629924774, -0.007648171856999397, -0.13116958737373352, 0.016342099756002426, -0.09596578776836395, 0.15481461584568024, 0.059565432369709015, -0.01837688498198986, -0.07799538969993591, 0.03304111957550049, 0.06202618032693863, 0.006278675980865955, -0.00046247709542512894, 0.0019986331462860107, -0.14515449106693268, 0.010333539918065071, 0.06726758927106857, 0.09123878926038742, 0.1428346186876297, -0.12614762783050537, -0.003625317011028528, 0.06684330105781555, -0.18021374940872192, 0.015030764043331146, -0.018710685893893242, 0.039814554154872894, -0.10060936212539673, -0.012531336396932602, -0.13581299781799316, 0.04474857822060585, -0.022028882056474686, -0.07970455288887024, -0.03334914147853851, 0.016477657482028008, 0.08563120663166046, 0.0459335520863533, -0.12229011952877045, -0.0027659134939312935, -0.014315485954284668, 0.14283013343811035, 0.008486175909638405, -0.08922279626131058, -0.11863763630390167, -0.07464994490146637, 0.024356290698051453, -0.04081514850258827, 0.06340089440345764, -0.10902592539787292, 0.02300291322171688, 0.0036983266472816467, 0.11618097126483917, -0.00652735261246562, -0.044778648763895035, -0.07417845726013184, 0.013195905834436417, -0.013603266328573227, 0.07824669033288956, -0.08886052668094635, -0.001886129379272461, 0.1356809288263321, -0.08660049736499786, 0.2581658959388733, 0.11023559421300888, 0.1441000998020172, 0.07082468271255493, -0.19191065430641174, 0.03938765823841095, 0.028131190687417984, -0.06946278363466263, -0.00457080639898777, -0.006321978755295277, 0.03560945391654968, 0.06289297342300415, 0.12663665413856506, 0.13098624348640442, -0.0019089503912255168, 0.1811627447605133, -0.013201622292399406, 0.0377063974738121, -0.12768062949180603, -0.08943314850330353, -0.11315450072288513, -0.04776621609926224, 0.012776275165379047, 0.008970570750534534, -0.04673828184604645, -0.0022608139552176, -0.054507143795490265, -0.09539532661437988, -0.022344613447785378, -0.07465485483407974, -0.09816060960292816, -0.01892302744090557, -0.0020849592983722687, 0.11308817565441132, 0.021458260715007782, -0.15308038890361786, 0.04266738519072533, -0.06718815863132477, 0.0339558869600296, -0.21192136406898499, 0.2166815996170044, 0.02894977107644081, -0.07181353121995926, 0.171890527009964, -0.07087165117263794, 0.023430485278367996, 0.013398922979831696, -0.04732903093099594, -0.11679396033287048, -0.012731124646961689, -0.029776951298117638, -0.19057847559452057, 7.993887619313548e-33, -0.011757688596844673, -0.013635771349072456, 0.02615491859614849, 0.012315412983298302, 0.003927222453057766, -0.05412322282791138, 0.019704686477780342, -0.05920470505952835, -0.126370370388031, -0.0077256448566913605, -0.14888933300971985, 0.019918859004974365, 0.016000675037503242, 0.06846331059932709, -0.013198144733905792, -0.11294697225093842, -0.031696781516075134, 0.013267762959003448, 0.05658051371574402, 0.019833436235785484, 0.057134486734867096, 0.1233360767364502, -0.04512261226773262, 0.12068308889865875, 0.02023674175143242, -0.055923398584127426, -0.060898154973983765, -0.07359530031681061, 0.06899403780698776, 0.04066098481416702, -0.012615743093192577, 0.023633074015378952, -0.04376900568604469, -0.12721464037895203, 0.028302650898694992, -0.06017684563994408, 0.005528370384126902, -0.06606251001358032, 0.01112870778888464, -0.007994737476110458, -0.016133397817611694, 0.007949252612888813, -0.06581686437129974, -0.0822349265217781, 0.06181354075670242, -0.005001327954232693, -0.06518539041280746, 0.15910941362380981, 0.04980943724513054, 0.03813648596405983, -0.08120179176330566, 0.03963780030608177, 0.03635992854833603, -0.09937644004821777, -0.021948525682091713, -0.04221503809094429, -0.17759060859680176, -0.09949465095996857, 0.05525136739015579, 0.17565682530403137, -0.01984477788209915, 0.1163766011595726, -0.0007057562470436096, 0.0387524738907814, -0.1272115707397461, 0.0838347002863884, -0.057605378329753876, -0.07470864057540894, -0.03050323761999607, 0.07392546534538269, -0.04427392780780792, 0.02024502120912075, 0.17374230921268463, 0.006495278794318438, -0.050703443586826324, -0.051561132073402405, 0.0708453357219696, 0.10148649662733078, 0.007496882230043411, 0.011058514006435871, -0.0357343964278698, -0.003504845779389143, -0.08112449944019318, 0.07623656094074249, 0.0270867720246315, -0.00977293774485588, 0.053507477045059204, -0.013555563986301422, -0.10240013152360916, -0.0069843921810388565, 0.05591094493865967, -0.11882787942886353, -0.08447787165641785, 0.17667782306671143, 0.03288584202528, -8.7029781378242e-33, 0.022358495742082596, -0.05994003266096115, 0.042385004460811615, -0.04655812680721283, 0.0018483763560652733, 0.15520527958869934, 0.05105457082390785, -0.057149745523929596, 0.11959025263786316, -0.04547269642353058, -0.03665723279118538, 0.09738126397132874, 0.04860413074493408, 0.0002455795183777809, -0.077034130692482, 0.06186259537935257, -0.12972477078437805, -0.1022191047668457, -0.05204062908887863, 0.1004393994808197, -0.08830404281616211, 0.19635282456874847, -0.057183533906936646, 0.10642263293266296, 0.11448980867862701, 0.12433549761772156, -0.0671963021159172, 0.22279402613639832, 0.06920890510082245, 0.03237554058432579, -0.09201091527938843, -0.009136784821748734, -0.3456754684448242, 0.03829433396458626, 0.004918173421174288, -0.03965944051742554, 0.057593949139118195, -0.10939309000968933, 0.17053836584091187, 0.05988349765539169, 0.05838802456855774, -0.044739458709955215, 0.0042318180203437805, 0.08572430908679962, 0.11998312175273895, -0.08725828677415848, 0.003551280125975609, -0.0331152006983757, 0.16347183287143707, -0.07089515775442123, -0.01893940567970276, 0.05058138817548752, 0.1343371421098709, 0.11485493183135986, -0.004351208917796612, -0.03706720098853111, 0.024447469040751457, 0.03608565032482147, 0.0072586024180054665, -0.045535676181316376, 0.14100922644138336, 0.017496496438980103, 0.03022465668618679, -0.0115005262196064, 0.00880248099565506, 0.011618842370808125, 0.019320711493492126, -0.09419195353984833, -0.02001342922449112, -0.07081805169582367, -0.07805435359477997, -0.14431682229042053, 0.19024521112442017, -0.0763329416513443, 0.17601782083511353, 0.10217832028865814, -0.06967036426067352, -0.1826115846633911, -0.1410292387008667, 0.029461432248353958, -0.009958039969205856, 0.07894540578126907, 0.03236418217420578, 0.03068470023572445, 0.03137168660759926, 0.10864949226379395, 0.03312751650810242, 0.023312315344810486, -0.003902860451489687, -0.05177506431937218, -0.1063668429851532, -0.09678091108798981, 0.05863644555211067, 0.15641996264457703, -0.011197993531823158, -1.0021169316587475e-07, 0.12695977091789246, -0.10821492969989777, 0.02922474592924118, -0.1344292163848877, 0.11383235454559326, -0.10301019251346588, -0.005682389251887798, -0.012164912186563015, 0.04306722804903984, 0.16593433916568756, 0.042687222361564636, 0.16145701706409454, -0.15379874408245087, 0.009721798822283745, -0.13269613683223724, -0.021242991089820862, -0.10913437604904175, 0.0015788376331329346, -0.05090285837650299, -0.07591688632965088, -0.12782366573810577, -0.037699952721595764, -0.028044018894433975, -0.023191098123788834, 0.07683642208576202, -0.043469976633787155, 0.08849014341831207, -0.06316375732421875, -0.007738541346043348, 0.07848533242940903, 0.0640089362859726, -0.03639737516641617, 0.09385940432548523, 0.10749790072441101, -0.020880289375782013, -0.0886317640542984, -0.03849869221448898, 0.13118883967399597, 0.027281329035758972, 0.09956800937652588, 0.002580106258392334, -0.05975855514407158, -0.07200204581022263, 0.03876013681292534, -0.008247733116149902, 0.0021399138495326042, -0.2869400978088379, 0.01706390269100666, -0.0001479964703321457, -0.0777902901172638, 0.04039818048477173, 0.017712105065584183, -0.06998966634273529, 0.016506945714354515, 0.024538636207580566, 0.0811886116862297, -0.12300556153059006, -0.0679398775100708, 0.01415177620947361, -0.03472341597080231, -0.029134336858987808, -0.14608176052570343, 0.06362710893154144, 0.022997360676527023], "changes": {"1wk": -2.0434208042288087}}, {"text": "LIVE The latest news and updates on Trump's tariffs The 4.5% return this week takes BioCryst Pharmaceuticals' (NASDAQ:BCRX) shareholders five-year gains to 127% editorial-team@simplywallst.com (Simply Wall St) Fri, Dec 27, 2024, 1:40 PM 3 min read In This Article: BCRX When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose your money. But on the bright side, if you buy shares in a high quality company at the right price, you can gain well over 100%. For instance, the price of BioCryst Pharmaceuticals, Inc. ( NASDAQ:BCRX ) stock is up an impressive 127% over the last five years. Better yet, the share price has risen 4.5% in the last week. But this might be partly because the broader market had a good week last week, gaining 2.8%. Since the stock has added US$68m to its market cap in the past week alone, let's see if underlying performance has been driving long-term returns. View our latest analysis for BioCryst Pharmaceuticals BioCryst Pharmaceuticals isn't currently profitable, so most analysts would look to revenue growth to get an idea of how fast the underlying business is growing. Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. That's because it's hard to be confident a company will be sustainable if revenue growth is negligible, and it never makes a profit. In the last 5 years BioCryst Pharmaceuticals saw its revenue grow at 46% per year. Even measured against other revenue-focussed companies, that's a good result. So it's not entirely surprising that the share price reflected this performance by increasing at a rate of 18% per year, in that time. So it seems likely that buyers have paid attention to the strong revenue growth. BioCryst Pharmaceuticals seems like a high growth stock - so growth investors might want to add it to their watchlist. The image below shows how earnings and revenue have tracked over time (if you click on the image you can see greater detail). NasdaqGS:BCRX Earnings and Revenue Growth December 27th 2024 We consider it positive that insiders have made significant purchases in the last year. Even so, future earnings will be far more important to whether current shareholders make money. This free report showing analyst forecasts should help you form a view on BioCryst Pharmaceuticals A Different Perspective BioCryst Pharmaceuticals shareholders have received returns of 27% over twelve months, which isn't far from the general market return. That gain looks pretty satisfying, and it is even better than the five-year TSR of 18% per year. Even if the share price growth slows down from here, there's a good chance that this is business worth watching in the long term. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. To that end, you should be aware of the 1 warning sign we've spotted with BioCryst Pharmaceuticals . Story Continues BioCryst Pharmaceuticals is not the only stock insiders are buying. So take a peek at this free list of small cap companies at attractive valuations which insiders have been buying. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "BCRX", "date": "2024-12-27T13:40:48", "sentiment": {"score": 0.672785397619009, "confidence": 0.707416832447052, "probabilities": {"positive": 0.707416832447052, "negative": 0.034631434828042984, "neutral": 0.2579517960548401}}, "embedding": [-0.029710479080677032, -0.07911241799592972, 0.0550353042781353, -0.046735331416130066, 0.014720682054758072, -0.013863738626241684, -0.01835786923766136, 0.07326136529445648, 0.10731911659240723, 0.07512395083904266, -0.1446591019630432, 0.07788270711898804, 0.0165785551071167, 0.0074696303345263, -0.0834374874830246, -0.012780506163835526, -0.020836804062128067, -0.008287806995213032, -0.1211872398853302, 0.06526871025562286, -0.08653952181339264, -0.10035054385662079, 0.03347424417734146, 0.03299275413155556, 0.053968846797943115, 0.021266544237732887, -0.05147003382444382, -0.04003030061721802, -0.07468755543231964, -0.06849180161952972, 0.028636086732149124, 0.10538879781961441, 0.13527408242225647, -0.0025253708008676767, -0.08650429546833038, 0.00804506428539753, -0.04136667400598526, 0.05335914343595505, 0.12286528199911118, 0.0377911739051342, -0.01915920339524746, 0.018372859805822372, -0.07410602271556854, 0.04169154539704323, -0.024897703900933266, -0.16017431020736694, 0.08890172839164734, 0.037322998046875, 0.08605272322893143, 0.009857209399342537, -0.21474580466747284, -0.005464937537908554, 0.04590523988008499, 0.009692460298538208, 0.002002062974497676, 0.04254039749503136, -0.0799451619386673, -0.055985163897275925, 0.08212846517562866, -0.03020434081554413, -0.01270538754761219, -0.007797722704708576, 0.11423713713884354, -0.01198051031678915, 0.17770208418369293, -0.04571918398141861, -0.03415284305810928, 0.03662046790122986, -0.103928342461586, -0.0005959079135209322, 0.06979914754629135, -0.030924340710043907, -0.04102605953812599, -0.015860754996538162, -0.08629439026117325, 0.11502368748188019, 0.06432735174894333, 0.07061860710382462, 0.10482050478458405, -0.033106185495853424, 0.09174156934022903, 0.027764588594436646, -0.07789067924022675, -0.0367119237780571, -0.002720715943723917, -0.009885072708129883, 0.17194920778274536, -0.016418028622865677, 0.0239642933011055, 0.03789117932319641, 0.12604805827140808, 0.0007867505773901939, -0.07697510719299316, -0.034391507506370544, -0.012581628747284412, 0.008644078858196735, -0.11514692008495331, -0.011546214111149311, 0.0688607394695282, 0.005606993567198515, 0.10125090181827545, 0.1079142838716507, -0.06345802545547485, -0.05328047275543213, -0.06520535796880722, -0.13530874252319336, 0.03413539379835129, 0.09407477080821991, 0.016532648354768753, 0.07477760314941406, -0.04847453534603119, 0.10818087309598923, -0.170268714427948, 0.022586042061448097, -0.05728819966316223, 0.03372972458600998, -0.011348754167556763, -0.08192269504070282, 0.025856297463178635, -0.02751358225941658, 0.050237152725458145, 0.084853395819664, -0.011210424825549126, -0.06941717863082886, -0.002436707727611065, 0.017101561650633812, -0.08768624067306519, 1.1416650193051637e-32, -0.08503850549459457, -0.0015710145235061646, 0.017770832404494286, -0.06944088637828827, -0.12418366968631744, 0.007816266268491745, -0.015949983149766922, -0.07300885021686554, -0.06974653899669647, -0.11126977205276489, -0.23018619418144226, 0.08059339970350266, -0.013093595393002033, -0.000726381316781044, 0.08985310792922974, -0.10561633855104446, -0.023692887276411057, -0.01192694716155529, 0.011289197951555252, -0.09013556689023972, 0.02317904122173786, 0.03866460546851158, -0.044711511582136154, 0.026352304965257645, 0.03709128126502037, -0.048910535871982574, -0.06408160924911499, 0.04744664579629898, -0.03309786692261696, 0.010796754620969296, 0.052722349762916565, 0.018784023821353912, -0.05872555822134018, -0.11876615881919861, -0.02632756158709526, -0.09249209612607956, -0.04333755746483803, 0.01860175095498562, 0.09970033168792725, 0.03742105886340141, -0.07705090939998627, 0.037693511694669724, -0.06483841687440872, -0.009108507074415684, -0.059756800532341, 0.030984658747911453, -0.13142508268356323, 0.02279454655945301, -0.06886674463748932, -0.003976740874350071, -0.022227689623832703, 0.017154410481452942, 0.01476591732352972, -0.10640519857406616, 0.0005914522334933281, 0.0798555538058281, -0.03621165081858635, -0.1645280122756958, 0.04372365400195122, 0.1548958420753479, -0.020768899470567703, 0.10962548851966858, -0.02015005424618721, 0.062114909291267395, -0.2027886062860489, 0.14176997542381287, 0.07421349734067917, 0.08400768041610718, -0.02338707074522972, 0.15644267201423645, 0.06909823417663574, -0.04049263522028923, 0.09405457973480225, -0.0898171067237854, 0.10871808230876923, -0.03680485486984253, -0.06748423725366592, 0.024247393012046814, 0.011853552423417568, 0.08458235114812851, 0.034651048481464386, -0.08674819767475128, 0.05236983671784401, 0.015998519957065582, -0.008664043620228767, -0.006591682322323322, 0.06264910101890564, -0.010119441896677017, -0.014679603278636932, 0.05592232570052147, 0.03968995437026024, -0.12004278600215912, -0.061315279453992844, 0.126595601439476, -0.06786594539880753, -9.920067356250334e-33, 0.07830555737018585, 0.02297089621424675, 0.09036768972873688, -0.07263200730085373, -0.09535017609596252, -0.004695605020970106, 0.0541650727391243, -0.0026142876595258713, -0.0640973374247551, -0.05314251035451889, -0.007745042443275452, 0.10310058295726776, -0.01986083947122097, 0.10436804592609406, -0.041648562997579575, 0.035968564450740814, 0.14591780304908752, -0.07859589159488678, -0.04600132256746292, -0.09369872510433197, -0.058873116970062256, 0.1502034217119217, -0.10459364950656891, 0.025975428521633148, -0.032940369099378586, 0.097244992852211, -0.046446651220321655, 0.16170920431613922, 0.0467255562543869, -0.06103759631514549, -0.11181420087814331, 0.028294038027524948, -0.10450804233551025, 0.018619932234287262, 0.03225648030638695, 0.056959912180900574, -0.02301521599292755, -0.18201720714569092, 0.08339931815862656, -0.05081276595592499, 0.09210128337144852, 0.050290003418922424, 0.02724628522992134, 0.029916120693087578, 0.11251387000083923, 0.02894756570458412, 0.005875858478248119, 0.040270235389471054, 0.15598353743553162, 0.13806188106536865, 0.07557803392410278, 0.0749787986278534, 0.05635455623269081, 0.06966105103492737, -0.10001197457313538, 0.08411246538162231, -0.08698911964893341, -0.007847080938518047, -0.039019547402858734, 0.008572248741984367, 0.03448225557804108, 0.054539185017347336, 0.0005188309587538242, 0.027634860947728157, -0.06702986359596252, -0.006271940656006336, 0.011765096336603165, -0.13488684594631195, 0.10688949376344681, -0.10125012695789337, 0.026132304221391678, -0.09529270976781845, 0.03991314396262169, -0.06056346371769905, -0.1010732650756836, 0.24198904633522034, -0.07434850186109543, -0.05857878178358078, -0.06355001032352448, 0.0397588312625885, 0.008011575788259506, 0.08875207602977753, 0.037342581897974014, -0.03211093693971634, -0.11594487726688385, 0.059879787266254425, 0.00393287418410182, -0.0940408855676651, -0.058517709374427795, 0.009725671261548996, -0.06136868894100189, -0.16158407926559448, -0.10799011588096619, 0.009698388166725636, 0.05764481797814369, -9.984711368815624e-08, 0.030459031462669373, -0.08706717193126678, 0.062019623816013336, -0.022255858406424522, 0.1321066915988922, -0.07256217300891876, 0.062859445810318, -0.033136531710624695, 0.12472793459892273, 0.10568930953741074, 0.11854478716850281, 0.04724804684519768, -0.18650326132774353, 0.06716644018888474, -0.09888651967048645, 0.08652834594249725, -0.11703826487064362, -0.001445711124688387, -0.011226849630475044, -0.15638139843940735, -0.039557717740535736, 0.09625415503978729, 0.10887951403856277, 0.0578787699341774, 0.05086947977542877, 0.02949754148721695, -0.027106165885925293, -0.02864863909780979, -0.05788718909025192, 0.02496124617755413, 0.11307945102453232, -0.04501354321837425, 0.08362090587615967, 0.06379177421331406, 0.0735732764005661, -0.0169394351541996, -0.029331866651773453, 0.009365237317979336, 0.053133752197027206, 0.08984710276126862, 0.0028412567917257547, 0.0005417121574282646, 0.0411296971142292, 0.0020987456664443016, -0.031542785465717316, -0.10497637093067169, -0.15534630417823792, 0.11686047911643982, 0.05571684241294861, -0.1973021924495697, 0.13736788928508759, -0.04899337887763977, -0.07933437824249268, -0.008219636976718903, 0.029446860775351524, 0.030556803569197655, -0.14933472871780396, -0.005729404743760824, -0.14100950956344604, -0.004703039303421974, 0.004222514107823372, -0.15550479292869568, 0.0620078444480896, 0.08106225728988647], "changes": {"1wk": 1.5564187414442983, "1mo": -0.90791402483833}}, {"text": "LIVE The latest news and updates on Trump's tariffs PREMIUM KalVista Pharmaceuticals' Sebetralstat Poised to Disrupt Acute HAE Market With Oral Advantage, BofA Says MT Newswires Wed, Dec 18, 2024, 6:54 PM 1 min read In This Article: KALV KalVista Pharmaceuticals' (KALV) drug candidate sebetralstat is a promising, on-demand oral treatmen PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "BCRX", "date": "2024-12-18T18:54:49", "sentiment": {"score": 0.1444693338125944, "confidence": 0.15332792699337006, "probabilities": {"positive": 0.15332792699337006, "negative": 0.008858593180775642, "neutral": 0.8378134369850159}}, "embedding": [-0.14545197784900665, -0.0594087578356266, -0.0736021026968956, -0.04581683874130249, -0.04108378291130066, 0.027674412354826927, 0.04918691888451576, 0.17748159170150757, -0.06420126557350159, 0.03549285978078842, -0.08205047249794006, 0.09017373621463776, -0.09805207699537277, -0.0059984177350997925, 0.07698439806699753, -0.0129897715523839, 0.1866735965013504, -0.07997424900531769, -0.030516568571329117, 0.04584813490509987, -0.04642154648900032, 0.05255161225795746, 0.10899952799081802, 0.017120350152254105, -0.02429775521159172, 0.056621164083480835, -0.1328704059123993, -0.14739403128623962, -0.01761971227824688, -0.08930956572294235, -0.06545816361904144, 0.005993432365357876, 0.17178185284137726, -0.09103254228830338, -0.019785337150096893, -0.027322761714458466, -0.26131585240364075, 0.060436539351940155, -0.03799647465348244, 0.06797722727060318, 0.07411827147006989, -0.2551526427268982, -0.22413919866085052, 0.09995296597480774, -0.10646232217550278, -0.17792290449142456, -0.08936207741498947, 0.041553933173418045, 0.0599391832947731, 0.22411833703517914, -0.1241414025425911, -0.12430450320243835, 0.07521840929985046, -0.09739267826080322, -0.10314135253429413, -0.10779400169849396, -0.1426149308681488, 0.018758876249194145, 0.038101524114608765, 0.15173804759979248, 0.01820724457502365, -0.022424492985010147, -0.07955211400985718, 0.10747481882572174, -0.06834326684474945, -0.01636471226811409, -0.016158826649188995, 0.01741109974682331, -0.04719987511634827, 0.00042760567157529294, 0.03887653350830078, -0.052696701139211655, -0.024084925651550293, 0.0733313336968422, 0.05139554291963577, -0.058720123022794724, 0.29757845401763916, -0.0008206419879570603, 0.057297468185424805, -0.053456809371709824, 0.11416755616664886, -0.04767656698822975, 0.07122564315795898, -0.0005694557330571115, -0.020411424338817596, -0.08373043686151505, -0.07208789885044098, -0.030815716832876205, 0.08114307373762131, -0.06699182093143463, 0.16851133108139038, 0.0022044721990823746, -0.014538074843585491, -0.054819393903017044, -0.03056841529905796, 0.037928540259599686, -0.15819936990737915, 0.009297756478190422, -0.11963897198438644, 0.10548810660839081, 0.0198387298732996, -0.005508906673640013, -0.1250476837158203, -0.07288037240505219, -0.09154332429170609, -0.13756564259529114, -0.10962668806314468, -0.060686882585287094, 0.05477244406938553, 0.04267555847764015, -0.00029020500369369984, 0.04752260074019432, 0.07556729763746262, -0.09076682478189468, -0.01839648373425007, 0.13013856112957, -0.009989633224904537, -0.1257004737854004, 0.16619594395160675, -0.040663134306669235, 0.054163042455911636, 0.016761351376771927, -0.030696451663970947, -0.024898439645767212, 0.03933955356478691, 0.022370919585227966, -0.026410942897200584, 1.1574909201554749e-32, -0.06473945826292038, 0.0656680315732956, 0.06892907619476318, -0.010058353655040264, -0.0620381236076355, 0.04184560850262642, 0.031743697822093964, -0.11811619997024536, -0.22240209579467773, -0.10594303160905838, -0.10877404361963272, 0.10168884694576263, -0.03993171080946922, 0.1530279964208603, -0.12105989456176758, -0.062010131776332855, -0.08415538817644119, 0.023418013006448746, 0.12412561476230621, -0.030840886756777763, 0.20038171112537384, -0.04655085876584053, -0.031431395560503006, 0.2107291966676712, -0.08532387763261795, 0.09091414511203766, 0.05548600107431412, -0.044071391224861145, 0.06625224649906158, 0.05897129327058792, -0.14749470353126526, 0.12088307738304138, 0.060792699456214905, -0.054658595472574234, -0.030790064483880997, 0.12114311754703522, -0.1842813342809677, -0.03422868624329567, -0.12447655200958252, -0.11957263201475143, -0.057463712990283966, 0.08615593612194061, -0.0642525777220726, 0.06165691092610359, -0.048097580671310425, -0.06722141802310944, -0.1278950423002243, 0.02858373150229454, 0.1162906289100647, -0.0785956084728241, -0.10496702045202255, 0.07445509731769562, -0.044111404567956924, 0.07615337520837784, -0.09145668148994446, 0.14938385784626007, -0.11531306803226471, -0.1287001520395279, 0.13582582771778107, -0.0003580116026569158, 0.16500848531723022, -0.060100436210632324, 0.011668375693261623, 0.01302773505449295, -0.1636343002319336, 0.030956625938415527, -0.14344297349452972, -0.11595985293388367, -0.1781192421913147, 0.03651277348399162, 0.11364138871431351, 0.07694040983915329, -0.031511303037405014, -0.029454359784722328, -0.051597487181425095, 0.023019885644316673, -0.017925025895237923, 0.16140544414520264, 0.06931430846452713, 0.1279374212026596, 0.026641258969902992, -0.11030382663011551, 0.19332745671272278, 0.0683237835764885, 0.003087082877755165, -0.024805739521980286, -0.025580156594514847, -0.046914760023355484, 0.055099356919527054, 0.15243969857692719, -0.1345231533050537, -0.08319482952356339, -0.08149493485689163, 0.055579256266355515, 0.007467424031347036, -1.532652880956285e-32, -0.05933452397584915, 0.013493726029992104, 0.035435132682323456, 0.09969376772642136, 0.0016620614333078265, 0.08595383912324905, 0.0690193846821785, 0.1962696760892868, 0.07379677891731262, 0.11599096655845642, 0.14758072793483734, 0.1124541163444519, -0.037423014640808105, 0.03417550027370453, 0.0643356665968895, -0.011496077291667461, 0.0919574499130249, -0.005247578956186771, -0.17322295904159546, 0.0879179984331131, 0.020162466913461685, 0.1924000382423401, -0.1054096445441246, 0.20484237372875214, 0.059300053864717484, -0.09317771345376968, 0.04768584668636322, -0.03718249499797821, -0.12276098132133484, 0.05422651395201683, -0.15645837783813477, -0.02578759752213955, -0.15027396380901337, 0.053092289716005325, -0.15825891494750977, 0.06056453660130501, 0.11766106635332108, 0.028645537793636322, -0.14118371903896332, -0.03371799737215042, 0.14320623874664307, 0.03487246483564377, -0.034199848771095276, 0.06424358487129211, 0.06341192871332169, 0.06518907845020294, -0.0760883241891861, 0.057083722203969955, 0.030595550313591957, -0.04961754009127617, -0.013919658027589321, 0.17207953333854675, -0.021884335204958916, 0.002265963237732649, -0.1278577446937561, 0.03244240581989288, -0.00678128469735384, -0.035457294434309006, -0.07559260725975037, 0.026195013895630836, 0.029615607112646103, 0.06868144124746323, -0.09360157698392868, -0.17697817087173462, 0.10246306657791138, -0.031929291784763336, 0.09888137131929398, -0.003652825951576233, 0.12054648250341415, -0.07860655337572098, -0.024431375786662102, -0.15971548855304718, -0.07405790686607361, -0.18136413395404816, 0.0462467335164547, 0.020110536366701126, -0.029927052557468414, 0.05978900194168091, -0.05949065089225769, -0.0010332565288990736, 0.14462575316429138, -0.1365150511264801, 0.0309425238519907, -0.05844379961490631, 0.08780543506145477, 0.01689879037439823, 0.06769983470439911, -0.056300319731235504, -0.03106590174138546, 0.07106546312570572, -0.2581850290298462, -0.13020183145999908, -0.2083161473274231, 0.09539458900690079, 0.09358802437782288, -1.0050327858834862e-07, 0.15469691157341003, -0.06879950314760208, -0.03584153950214386, 0.06340067088603973, 0.02084352821111679, -0.03839776664972305, -0.16964633762836456, 0.0036243691574782133, -0.05695540830492973, 0.18809504806995392, -0.03065650537610054, 0.1462150514125824, 0.02728606015443802, -0.03407134860754013, -0.03496768698096275, 0.05906495451927185, 0.0273063275963068, 0.1595696061849594, -0.03441300988197327, -0.12349337339401245, -0.047845665365457535, 0.14483927190303802, 0.05912499502301216, 0.007885556668043137, 0.11643414944410324, 0.05262308940291405, -0.10239467769861221, 0.03947266936302185, 0.16521450877189636, -0.05285269767045975, -0.07890579849481583, 0.052976105362176895, -0.10016188025474548, 0.013008533045649529, -0.009591694921255112, -0.017984138801693916, -0.0013580096419900656, 0.003978492226451635, 0.10295891016721725, 0.05896192416548729, -0.1335475891828537, -0.016157178208231926, 0.04821345582604408, 0.015712063759565353, -0.1290588527917862, 0.1134323999285698, -0.138204887509346, -0.03575989231467247, 0.15860483050346375, 0.0239899680018425, -0.1073363870382309, -0.06864602863788605, 0.11086919158697128, -0.042490482330322266, 0.10952844470739365, 0.051227353513240814, 0.05285290256142616, -0.16108232736587524, 0.049257613718509674, 0.00339041231200099, 0.16157075762748718, -0.2721213400363922, 0.07725529372692108, 0.10276324301958084], "changes": {"1wk": 4.924762466927168, "1mo": 1.9151828670516025}}, {"text": "LIVE The latest news and updates on Trump's tariffs PREMIUM BioCryst Pharmaceuticals' Hereditary Angioedema Drug Gets Recommendation From Ireland Regulator MT Newswires Mon, Nov 18, 2024, 11:48 AM In This Article: BCRX BioCryst Pharmaceuticals' Hereditary Angioedema Drug Gets Recommendation From Ireland Regulator PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "BCRX", "date": "2024-11-18T11:48:20", "sentiment": {"score": 0.028685595840215683, "confidence": 0.044357553124427795, "probabilities": {"positive": 0.044357553124427795, "negative": 0.015671957284212112, "neutral": 0.9399704933166504}}, "embedding": [-0.02884828671813011, -0.050939034670591354, 0.005718677770346403, -0.03769544139504433, 0.28123196959495544, -0.018835801631212234, -0.04633628949522972, 0.212812140583992, -0.06878473609685898, -0.06216762959957123, -0.05771401897072792, 0.04363754764199257, -0.09082972258329391, 0.11085496097803116, -0.07522407174110413, 0.10756997019052505, -0.0761767029762268, -0.13466472923755646, 0.0021832080092281103, 0.11352524906396866, -0.06359559297561646, 0.18612425029277802, 0.0714847594499588, 0.06627565622329712, 0.03544024005532265, 0.12393734604120255, -0.036244649440050125, -0.11528243869543076, -0.0631219893693924, -0.028602099046111107, 0.04162627458572388, -0.09555335342884064, -0.06555823981761932, -0.0795014277100563, 0.07170666754245758, -0.13041101396083832, -0.20682696998119354, 0.03213457763195038, -0.024469058960676193, 0.1312498301267624, 0.06995062530040741, -0.19689154624938965, -0.11272387951612473, -0.008077846840023994, 0.09712301939725876, 0.009100590832531452, -0.06912185996770859, 0.018593477085232735, 0.07066065818071365, 0.2049517035484314, -0.20371682941913605, -0.23105329275131226, -0.012935856357216835, 0.006435756105929613, 0.12273266166448593, -0.13405397534370422, -0.2465798556804657, -0.09208060801029205, 0.029181791469454765, -0.021054640412330627, -0.014230828732252121, -0.023657461628317833, -0.10717932134866714, -0.02303704060614109, -0.056486815214157104, 0.025838792324066162, -0.014264997094869614, -0.07005589455366135, 0.0544438362121582, -0.10305093973875046, 0.03250674158334732, 0.05250382050871849, 0.018756704404950142, 0.2083692103624344, -0.0737406462430954, 0.06492145359516144, 0.13261377811431885, 0.07930395752191544, 0.13139508664608002, -0.09881026297807693, 0.03551897406578064, -0.007263632025569677, 0.009680488146841526, -0.04578307271003723, 0.19530251622200012, -0.03025035187602043, -0.00396638223901391, -0.06890783458948135, 0.03758660703897476, -0.05444955453276634, 0.1386985182762146, 0.04003233462572098, 0.036259427666664124, 0.10040935128927231, -0.1187625527381897, -0.04246486723423004, -0.027812425047159195, 0.06823607534170151, -0.23935934901237488, 0.07035975903272629, -0.10513480007648468, -0.03291454166173935, -0.09150037914514542, 0.006669979076832533, -0.166809543967247, -0.062443528324365616, -0.035553716123104095, 0.0056409528478980064, 0.12536878883838654, 0.03797764331102371, -0.04904080182313919, 0.10511250793933868, 0.049203258007764816, -0.1435200572013855, -0.06272371858358383, 0.047815822064876556, -0.12186704576015472, -0.17042216658592224, 0.0913480669260025, 0.0074882409535348415, -0.05040661245584488, 0.010372363030910492, -0.060904599726200104, -0.036596767604351044, 0.06821760535240173, 0.05452437326312065, -0.1740696132183075, 1.3573951955827254e-32, 0.027522508054971695, 0.08695380389690399, -0.00877379160374403, 0.09335919469594955, 0.043133676052093506, 0.016922928392887115, -0.028582129627466202, -0.16769471764564514, -0.15931452810764313, -0.2208433598279953, -0.1615801304578781, 0.0735534206032753, -0.08945481479167938, 0.21648317575454712, -0.18831631541252136, -0.1700352281332016, -0.056516654789447784, 0.05754862353205681, 0.04218606278300285, 0.09327802807092667, 0.18835052847862244, 0.048920638859272, -0.040205735713243484, 0.05044960603117943, -0.0882047489285469, 0.091051384806633, 0.0509423092007637, -0.0687025934457779, 0.24869351089000702, 0.11448690295219421, -0.189267098903656, 0.02712639607489109, 0.034854620695114136, -0.22581756114959717, -0.0032233151141554117, 0.043295592069625854, -0.008264560252428055, -0.02621256373822689, -0.09081341326236725, 0.10580087453126907, 0.02468501403927803, 0.04366610199213028, -0.12159060686826706, 0.08308428525924683, 0.07006607204675674, -0.14757917821407318, -0.000418757350416854, 0.02730744518339634, 0.08325502276420593, -0.24776293337345123, -0.02691676840186119, -0.08208376169204712, -0.013218912295997143, 0.014324725605547428, 0.06464184820652008, -0.034600820392370224, -0.3111107349395752, -0.08275610208511353, 0.07457856088876724, -0.007537295576184988, 0.2602088749408722, 0.07802639901638031, 0.06944895535707474, -0.015392971225082874, -0.09672631323337555, 0.041752055287361145, -0.020021170377731323, -0.03565487265586853, -0.13136351108551025, -0.02008744142949581, 0.1624375730752945, 0.05520593747496605, 0.10360078513622284, -0.042452555149793625, -0.16184672713279724, -0.05971285700798035, -0.09580056369304657, 0.16495509445667267, 0.025735320523381233, -0.05080867558717728, -0.0882282480597496, -0.09872517734766006, 0.1998462826013565, 0.1308509260416031, 0.03627487272024155, -0.051981121301651, 0.10783153772354126, -0.08763284236192703, -0.04969753324985504, 0.10821849852800369, -0.0772048756480217, -0.060403160750865936, -0.03854838013648987, 0.0550113320350647, -0.04765820875763893, -1.517585247430651e-32, 0.024211440235376358, -0.06562162190675735, 0.09823507070541382, -0.10903517156839371, -0.08874465525150299, 0.12012362480163574, -0.08513494580984116, 0.016578877344727516, 0.3375840485095978, 0.07393541932106018, 0.029219672083854675, 0.10080481320619583, 0.01870979368686676, -0.00304846721701324, 0.04096413776278496, -0.04683556780219078, -0.017048466950654984, -0.03296758607029915, -0.160072460770607, 0.0786166861653328, 0.04586102440953255, 0.09701155871152878, -0.15696588158607483, 0.19449947774410248, 0.04647008702158928, 0.05477754771709442, 0.017980186268687248, 0.10922937095165253, -0.043496888130903244, -0.20873147249221802, -0.18425139784812927, 0.028400860726833344, -0.18047581613063812, -0.07334164530038834, -0.16699838638305664, 0.11734601855278015, 0.05032521113753319, -0.02951543591916561, 0.07319852709770203, 0.0517360083758831, 0.09426914155483246, -0.0882415771484375, -0.1664828658103943, 0.07049161940813065, 0.10072077065706253, 0.00011915305367438123, -0.08075650036334991, 0.0571107342839241, 0.16708526015281677, -0.031805358827114105, -0.02132062055170536, 0.1102372482419014, 0.06271743029356003, 0.04182988032698631, -0.12193065136671066, -0.12760154902935028, 0.0978265181183815, 0.011967439204454422, 0.042726967483758926, 0.046515364199876785, 0.06261659413576126, 0.023801693692803383, -0.15075217187404633, -0.015425095334649086, 0.0963774025440216, 0.11356346309185028, -0.010615321807563305, -0.16780221462249756, 0.2210467904806137, 0.0070799426175653934, -0.09156041592359543, -0.15418247878551483, -0.09662482887506485, -0.07620953023433685, 0.12042515724897385, 0.14277592301368713, 0.0479922890663147, 0.10074643045663834, 0.011751570738852024, 0.010219408199191093, 0.14354746043682098, -0.0787573829293251, 0.12215089052915573, -0.1960916370153427, 0.0486585907638073, 0.0017044207779690623, 0.18255376815795898, -0.12458642572164536, -0.15780527889728546, -0.007341615855693817, -0.17891989648342133, -0.2828943133354187, -0.15173527598381042, -0.0018719985382631421, 0.04040314629673958, -1.0050550258711155e-07, 0.09686000645160675, 0.016750162467360497, -0.042683929204940796, 0.05621492117643356, -0.01517060212790966, 0.003027617698535323, -0.043383996933698654, 0.05460251122713089, 0.010428129695355892, 0.12424053251743317, -0.0735817477107048, 0.061432115733623505, 0.025397488847374916, -0.07393837720155716, 0.14114756882190704, -0.08032935857772827, 0.08240130543708801, 0.08761505782604218, -0.06043894216418266, -0.0722511038184166, 0.010081776417791843, 0.13007405400276184, 0.16907145082950592, -0.05793008953332901, 0.02100077085196972, -0.0857212170958519, 0.0849042758345604, -0.016839997842907906, -0.003385057207196951, 0.14209605753421783, -0.042542729526758194, -0.037241511046886444, -0.05823954567313194, 0.0137085085734725, 0.041042983531951904, -0.08101710677146912, -0.04382628574967384, 0.037302277982234955, 0.06484433263540268, -0.010562281124293804, 0.092491015791893, -0.088246189057827, -0.008119960315525532, 0.011528442613780499, 0.017491275444626808, -0.03156094253063202, -0.055160537362098694, -0.07711463421583176, 0.20025864243507385, 0.028674697503447533, 0.05153478682041168, -0.10315651446580887, 0.1502617597579956, -0.1607334315776825, -0.00520881125703454, 0.08383214473724365, -0.09414965659379959, -0.08925146609544754, -0.057469140738248825, -0.03861825540661812, 0.22247567772865295, -0.16469451785087585, 0.13116493821144104, 0.1967121660709381], "changes": {"1wk": 7.6487247341312, "1mo": 6.090649175973377}}, {"text": "LIVE The latest news and updates on Trump's tariffs BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Is Expected To Breakeven In The Near Future editorial-team@simplywallst.com (Simply Wall St) Mon, Nov 25, 2024, 7:56 PM 3 min read In This Article: BCRX BioCryst Pharmaceuticals, Inc. ( NASDAQ:BCRX ) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. BioCryst Pharmaceuticals, Inc., a biotechnology company, develops oral small-molecule and protein therapeutics to treat rare diseases. The US$1.6b market-cap company\u2019s loss lessened since it announced a US$227m loss in the full financial year, compared to the latest trailing-twelve-month loss of US$124m, as it approaches breakeven. Many investors are wondering about the rate at which BioCryst Pharmaceuticals will turn a profit, with the big question being \u201cwhen will the company breakeven?\u201d In this article, we will touch on the expectations for the company's growth and when analysts expect it to become profitable. View our latest analysis for BioCryst Pharmaceuticals Consensus from 10 of the American Biotechs analysts is that BioCryst Pharmaceuticals is on the verge of breakeven. They expect the company to post a final loss in 2025, before turning a profit of US$74m in 2026. So, the company is predicted to breakeven approximately 2 years from today. How fast will the company have to grow each year in order to reach the breakeven point by 2026? Working backwards from analyst estimates, it turns out that they expect the company to grow 73% year-on-year, on average, which is extremely buoyant. If this rate turns out to be too aggressive, the company may become profitable much later than analysts predict. NasdaqGS:BCRX Earnings Per Share Growth November 25th 2024 Given this is a high-level overview, we won\u2019t go into details of BioCryst Pharmaceuticals' upcoming projects, however, take into account that by and large a biotech has lumpy cash flows which are contingent on the product type and stage of development the company is in. So, a high growth rate is not out of the ordinary, particularly when a company is in a period of investment. Before we wrap up, there\u2019s one issue worth mentioning. BioCryst Pharmaceuticals currently has negative equity on its balance sheet. Accounting methods used to deal with losses accumulated over time can cause this to occur. This is because liabilities are carried forward into the future until it cancels. These losses tend to occur only on paper, however, in other cases it can be forewarning. Next Steps: There are key fundamentals of BioCryst Pharmaceuticals which are not covered in this article, but we must stress again that this is merely a basic overview. For a more comprehensive look at BioCryst Pharmaceuticals, take a look at BioCryst Pharmaceuticals' company page on Simply Wall St . We've also compiled a list of essential factors you should further research: Story Continues Valuation : What is BioCryst Pharmaceuticals worth today? Has the future growth potential already been factored into the price? The intrinsic value infographic in our free research report helps visualize whether BioCryst Pharmaceuticals is currently mispriced by the market. Management Team : An experienced management team on the helm increases our confidence in the business \u2013 take a look at who sits on BioCryst Pharmaceuticals\u2019s board and the CEO\u2019s background . Other High-Performing Stocks : Are there other stocks that provide better prospects with proven track records? Explore our free list of these great stocks here . Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "BCRX", "date": "2024-11-25T19:56:45", "sentiment": {"score": 0.12647034227848053, "confidence": 0.27227261662483215, "probabilities": {"positive": 0.27227261662483215, "negative": 0.14580227434635162, "neutral": 0.581925094127655}}, "embedding": [-0.052618809044361115, -0.1016615629196167, 0.023165889084339142, -0.05471111088991165, 0.009033147245645523, -0.04311080276966095, -0.08990536630153656, 0.21649925410747528, 0.07964561879634857, 0.06823216378688812, -0.15573778748512268, 0.008074665442109108, 0.013326410204172134, 0.008431168273091316, -0.09356734156608582, 0.03384097293019295, -0.12683826684951782, -0.09508204460144043, -0.1453961431980133, 0.14031238853931427, 0.045842405408620834, -0.09856830537319183, -0.010446052998304367, 0.04364209622144699, 0.05968379229307175, 0.007497482001781464, 0.060048408806324005, -0.0548398494720459, -0.14633621275424957, -0.024375932291150093, -0.02795330621302128, 0.1250658929347992, 0.1536499261856079, -0.028714638203382492, 0.0035428497940301895, -0.030368754640221596, -0.11265502125024796, 0.06210971996188164, 0.09840080142021179, 0.022552069276571274, -0.0448555052280426, -0.03393056243658066, -0.10040751099586487, 0.08611144125461578, 0.022570764645934105, -0.18169686198234558, 0.04581238701939583, 0.0649881362915039, 0.056790903210639954, 0.03314825892448425, -0.21298231184482574, -0.061484843492507935, -0.015328843146562576, 0.05399361997842789, -0.007091646548360586, -0.008145428262650967, -0.09974369406700134, -0.15156911313533783, 0.04946044832468033, 0.016280997544527054, 0.05137407034635544, -0.03402312099933624, 0.08839087188243866, -0.03462286666035652, 0.2682417333126068, -0.054224517196416855, 0.006873652338981628, 0.03193521872162819, -0.16164778172969818, 0.059300199151039124, 0.029783468693494797, -0.12799109518527985, -0.08637809753417969, -0.02094772271811962, -0.01833232492208481, 0.10550372302532196, 0.11475146561861038, 0.12861812114715576, 0.0704617127776146, -0.08066709339618683, 0.11587635427713394, -0.05488262325525284, -0.10197023302316666, -0.12797118723392487, -0.09137161076068878, -0.028493328019976616, 0.13461533188819885, 0.06964562833309174, 0.16291742026805878, 0.003346748650074005, 0.06769518554210663, -0.010396376252174377, -0.029041355475783348, -0.03135082870721817, -0.005263760685920715, 0.05585727095603943, -0.09110775589942932, -0.035624708980321884, 0.12069453299045563, -0.03228846564888954, 0.08551408350467682, 0.018344365060329437, -0.03497392684221268, -0.08296312391757965, -0.026290323585271835, -0.18131935596466064, -0.021774640306830406, 0.059968866407871246, 0.08881214261054993, 0.05092170834541321, -0.01252722181379795, 0.11583566665649414, -0.05220019072294235, 0.03833674639463425, -0.10369688272476196, 0.08775953948497772, -0.025033604353666306, -0.07062366604804993, 0.07327886670827866, -0.03761635720729828, 0.022422119975090027, 0.1546209752559662, -0.06635379791259766, -0.1045563817024231, -0.07887567579746246, 0.005113275721669197, -0.17138391733169556, 8.319374658216547e-33, -0.04597992077469826, -0.014137386344373226, -0.009428300894796848, -0.04975225776433945, -0.12418985366821289, 0.05474868789315224, 0.012224379926919937, -0.01582224667072296, -0.06490375101566315, -0.12886591255664825, -0.23522967100143433, -0.05122779309749603, -0.02910848706960678, -0.016995176672935486, 0.08633819222450256, -0.18779593706130981, 0.03991972655057907, -0.008472987450659275, 0.0014154580421745777, -0.07966013252735138, -0.006976469419896603, 0.008577762171626091, -0.0774160698056221, 0.048890165984630585, 0.0670662447810173, -0.04620813578367233, -0.023818068206310272, -0.052871719002723694, -0.031108610332012177, 0.03139907121658325, 0.026146721094846725, 0.028834739699959755, -0.11733986437320709, -0.09373322129249573, -0.052562229335308075, -0.08856593817472458, -0.09629321098327637, 0.026242729276418686, 0.08344648778438568, 0.04461231082677841, -0.19497841596603394, 0.06752459704875946, -0.12077787518501282, 0.015017934143543243, 0.04320285841822624, 0.018252762034535408, -0.0006168559193611145, 0.05016639828681946, 0.007505709305405617, -0.09557396173477173, -0.04456469416618347, -0.009001650847494602, 0.031208625063300133, -0.057623155415058136, 0.11671778559684753, 0.09562857449054718, -0.02226370759308338, -0.21979205310344696, 0.007792484015226364, 0.18401792645454407, 0.03883647918701172, 0.19849920272827148, 0.005321142263710499, 0.002266400493681431, -0.226587176322937, 0.1967097818851471, 0.05170696601271629, 0.07684572786092758, -0.05892403423786163, 0.17867955565452576, 0.05467011779546738, -0.045073412358760834, 0.1588459461927414, -0.14909464120864868, 0.09662336111068726, 0.02828867919743061, 0.0759010910987854, 0.022455785423517227, 0.11894473433494568, 0.07589555531740189, 0.011083751916885376, -0.026250144466757774, 0.03576365113258362, 0.01564064435660839, -0.005583653226494789, -0.028108591213822365, 0.06523104012012482, -0.009881711564958096, -0.0440962016582489, 0.04889508709311485, 0.0066298507153987885, -0.13847491145133972, -0.03246144577860832, 0.18500655889511108, -0.04173186421394348, -9.255545706051109e-33, 0.06005338579416275, 0.015682915225625038, 0.048243407160043716, -0.0052427491173148155, -0.04306802898645401, -0.07711197435855865, 0.05595392733812332, 0.06928364932537079, 0.061684153974056244, -0.06498599797487259, 0.003905381541699171, 0.12445230782032013, 0.019178826361894608, 0.1464226245880127, -0.07098860293626785, 0.0025220203679054976, 0.1384582370519638, -0.0717451348900795, -0.10977154970169067, -0.01628483645617962, -0.054645173251628876, 0.11552207916975021, -0.17089876532554626, 0.04240422695875168, 0.022986169904470444, 0.06842683255672455, 0.053837135434150696, 0.12486276030540466, 0.01196473278105259, -0.07008153200149536, -0.1635049283504486, -0.047650717198848724, -0.1770884394645691, 0.09761261194944382, 0.0007026102393865585, 0.06344284862279892, -0.02797568216919899, -0.1801905632019043, 0.07004216313362122, -0.09588967263698578, 0.11877188086509705, 0.005732377525418997, -0.11308680474758148, -0.007188156247138977, 0.14521294832229614, -0.04757968708872795, 0.03703690320253372, 0.05501028895378113, 0.27262741327285767, 0.14865568280220032, 0.08041940629482269, 0.0447358638048172, 0.091375932097435, 0.06851837784051895, -0.13409271836280823, 0.03677606210112572, -0.011295477859675884, -0.03438614681363106, -0.11442262679338455, 0.039879005402326584, -0.027105528861284256, 0.04216029867529869, 0.12880045175552368, 0.06471032649278641, -0.06441108882427216, -0.030756954103708267, 0.00971763115376234, -0.103102907538414, 0.12013009190559387, -0.12591679394245148, 0.08340741693973541, 0.046480655670166016, 0.008388092741370201, -0.05392381548881531, -0.003821676131337881, 0.25663572549819946, -0.1156756728887558, -0.12737256288528442, -0.04841330647468567, 0.006295686587691307, 0.020229987800121307, 0.15621498227119446, 0.06058291345834732, -0.020940136164426804, -0.09879652410745621, 0.04576367884874344, 0.08494383096694946, -0.13128986954689026, -0.06814579665660858, -0.043343134224414825, -0.15505561232566833, -0.1654362678527832, -0.04218059778213501, 0.04686833173036575, 0.08576012402772903, -1.0024353969129152e-07, 0.06433998793363571, -0.018602967262268066, 0.039854176342487335, -0.09362214058637619, 0.22496765851974487, -0.06318844109773636, 0.02798815444111824, -0.058769341558218, 0.15004971623420715, 0.1454138308763504, 0.07523774355649948, 0.11465759575366974, -0.15848872065544128, 0.13753435015678406, -0.16107770800590515, 0.07387350499629974, -0.13706408441066742, -0.0032068067230284214, -0.037871912121772766, -0.1755920946598053, -0.045371219515800476, 0.07596753537654877, 0.0961008220911026, 0.040430307388305664, 0.0580681711435318, -0.08825375139713287, -0.039350058883428574, 0.04042241349816322, -0.09511801600456238, 0.04915839806199074, 0.07042888551950455, -0.06758636236190796, 0.02090403623878956, 0.09419429302215576, -0.009676729328930378, -0.09885671734809875, -0.05273759365081787, 0.058145828545093536, 0.08408505469560623, 0.12328914552927017, 0.014400949701666832, -0.05976124107837677, 0.025395743548870087, -0.011648928746581078, -0.02694069966673851, -0.15645381808280945, -0.1434028446674347, 0.07377992570400238, 0.06611068546772003, -0.16649678349494934, 0.14583031833171844, -0.05017514154314995, -0.0559234544634819, 0.04576359689235687, 0.18212257325649261, 0.04689325392246246, -0.15203198790550232, -0.014201361685991287, -0.18391403555870056, 0.03330055996775627, -0.011100606992840767, -0.19390124082565308, 0.07560423016548157, 0.07660648971796036], "changes": {"1wk": 1.513069240756525, "1mo": 5.502064599956907}}, {"text": "LIVE The latest news and updates on Trump's tariffs BioCryst Launches ORLADEYO\u00ae (berotralstat) in Ireland BioCryst Pharmaceuticals, Inc. Mon, Nov 18, 2024, 10:00 AM 5 min read In This Article: BCRX BioCryst Pharmaceuticals, Inc. RESEARCH TRIANGLE PARK, N.C., Nov. 18, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc.\u00a0(Nasdaq:\u00a0BCRX) today announced that the Health Services Executive (HSE) in Ireland has recommended ORLADEYO \u00ae (berotralstat) for the routine prevention of recurrent attacks of hereditary angioedema (HAE) in eligible patients 12 years and older. With this recommendation, HAE patients in Ireland will have access to the first oral, once-daily therapy for the reduction of recurrent HAE attacks. \u201cThe positive HSE recommendation of ORLADEYO\u00a0broadens access to modern prophylaxis, providing greater choice for prescribing physicians and potentially a better quality of life for HAE patients in Ireland,\u201d said Charlie Gayer, chief commercial officer of BioCryst. The HSE decision in Ireland follows the European Commission marketing authorization of ORLADEYO in April 2021. To date, ORLADEYO is licensed in 44 countries. About ORLADEYO \u00ae (berotralstat) ORLADEYO \u00ae (berotralstat) is the first and only oral therapy designed specifically to prevent attacks of hereditary angioedema (HAE) in adult and pediatric patients 12 years and older. One capsule of ORLADEYO per day works to prevent HAE attacks by decreasing the activity of plasma kallikrein. U.S. Indication and Important Safety Information INDICATION ORLADEYO \u00ae (berotralstat)\u00a0is a plasma kallikrein inhibitor indicated for prophylaxis to prevent attacks of hereditary angioedema (HAE) in adults and pediatric patients 12 years and older. Limitations of use The safety and effectiveness of ORLADEYO for the treatment of acute HAE attacks have not been established. ORLADEYO should not be used for the treatment of acute HAE attacks. Additional doses or dosages of ORLADEYO higher than 150 mg once daily are not recommended due to the potential for QT prolongation. IMPORTANT SAFETY INFORMATION An increase in QT prolongation was observed at dosages higher than the recommended 150 mg once-daily dosage and was concentration dependent. The most common adverse reactions (\u226510% and higher than placebo) in patients receiving ORLADEYO were abdominal pain, vomiting, diarrhea, back pain, and gastroesophageal reflux disease. A reduced dosage of 110 mg taken orally once daily with food is recommended in patients with moderate or severe hepatic impairment (Child-Pugh B or C). Berotralstat is a substrate of P-glycoprotein (P-gp) and breast cancer resistance protein. P-gp inducers (eg, rifampin, St. John\u2019s wort) may decrease berotralstat plasma concentration, leading to reduced efficacy of ORLADEYO. The use of P-gp inducers is not recommended with ORLADEYO. Story Continues ORLADEYO at a dose of 150 mg is a moderate inhibitor of CYP2D6 and CYP3A4. For concomitant medications with a narrow therapeutic index that are predominantly metabolized by CYP2D6 or CYP3A4, appropriate monitoring and dose titration is recommended. ORLADEYO at a dose of 300 mg is a P-gp inhibitor. Appropriate monitoring and dose titration is recommended for P-gp substrates (eg, digoxin) when coadministering with ORLADEYO. The safety and effectiveness of ORLADEYO in pediatric patients <12 years of age have not been established. There are insufficient data available to inform drug-related risks with ORLADEYO use in pregnancy. There are no data on the presence of berotralstat in human milk, its effects on the breastfed infant, or its effects on milk production. To report SUSPECTED ADVERSE REACTIONS, contact BioCryst Pharmaceuticals, Inc. at 1-833-633-2279 or the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch/ Please see full Prescribing Information . The Irish Summary of Product Characteristics (SPC) and Patient Information Leaflet (PIL) for ORLADEYO (berotralstat) can be found through medicines.ie. Anyone can report suspected side effects to the HPRA. You can submit a report by visiting the HPRA\u2019s reporting webpage to complete an online form hpra.ie/report . Adverse events should also be reported to BioCryst Pharmaceuticals at medinfoeurope@biocryst.com or +353 1 699 4405. About BioCryst Pharmaceuticals BioCryst Pharmaceuticals is a global biotechnology company with a deep commitment to improving the lives of people living with hereditary angioedema and other rare diseases. BioCryst leverages its expertise in structure-guided drug design to develop first-in-class or best-in-class oral small-molecule and protein therapeutics to target difficult-to-treat diseases. BioCryst has commercialized ORLADEYO \u00ae (berotralstat), the first oral, once-daily plasma kallikrein inhibitor, and is advancing a pipeline of small-molecule and protein therapies. For more information, please visit www.biocryst.com or follow us on LinkedIn . Forward-Looking Statements This press release contains forward-looking statements, including statements regarding BioCryst\u2019s plans and expectations for ORLADEYO. These statements involve known and unknown risks, uncertainties and other factors which may cause BioCryst\u2019s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. These statements reflect our current views with respect to future events and are based on assumptions and are subject to risks and uncertainties. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Some of the factors that could affect the forward-looking statements contained herein include: BioCryst\u2019s ability to successfully implement or maintain its commercialization plans for ORLADEYO; risks related to government actions, including that decisions and other actions, including as they relate to pricing, may not be taken when expected or at all, or that the outcomes of such decisions and other actions may not be in line with BioCryst\u2019s current expectations; the commercial viability of ORLADEYO, including its ability to achieve sustained market acceptance and demand; the FDA, HSE, or other applicable regulatory agency may require additional studies beyond the studies planned for products and product candidates, may not provide regulatory clearances which may result in delay of planned clinical trials, may impose certain restrictions, warnings, or other requirements on products and product candidates, may impose a clinical hold with respect to product candidates, or may withhold, delay or withdraw market approval for products and product candidates; BioCryst\u2019s ability to successfully manage its growth and compete effectively; and risks related to the international expansion of BioCryst\u2019s business. Please refer to the documents BioCryst files periodically with the Securities and Exchange Commission, specifically BioCryst\u2019s most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K, which identify important factors that could cause actual results to differ materially from those contained in BioCryst\u2019s projections and forward-looking statements. BCRXW Contact: John Bluth +1 919 859 7910 jbluth@biocryst.com Niamh Lyons +353 87 639 7083 nlyons@biocryst.com View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "BCRX", "date": "2024-11-18T10:00:00", "sentiment": {"score": 0.205580685287714, "confidence": 0.227769136428833, "probabilities": {"positive": 0.227769136428833, "negative": 0.022188451141119003, "neutral": 0.7500424385070801}}, "embedding": [-0.058694276958703995, 0.09820732474327087, -0.043165743350982666, -0.13550320267677307, 0.003880789503455162, 0.009479520842432976, -0.24060103297233582, 0.36217331886291504, 0.07750824093818665, 0.022512223571538925, -0.005533009767532349, 0.04560486227273941, 0.0012182928621768951, 0.07070907950401306, -0.025047115981578827, 0.10886143893003464, 0.03827855736017227, 0.006603846326470375, 0.004733767360448837, 0.09205718338489532, 0.04907941818237305, 0.12445943057537079, -0.06290102750062943, 0.13941048085689545, -0.037671126425266266, 0.06279611587524414, -0.07200884073972702, 0.009740513749420643, -0.08728966116905212, 0.07782252877950668, 0.04429859668016434, -0.0506206713616848, -0.019843142479658127, -0.06114209443330765, -0.024624180048704147, -0.049062617123126984, -0.25473642349243164, -0.027765801176428795, -0.2041652351617813, 0.1368369460105896, -0.07138089835643768, -0.09241478145122528, -0.21551935374736786, -0.1342214047908783, 0.09034194052219391, -0.07011714577674866, -0.07058928906917572, 0.09019751846790314, 0.04729461669921875, 0.17114099860191345, -0.10062286257743835, -0.09193181991577148, -0.05924295261502266, 0.08600115776062012, 0.04421459510922432, -0.07263417541980743, -0.1297580450773239, -0.03242567181587219, 0.010769594460725784, 0.028456348925828934, -0.1383616030216217, -0.04718201607465744, -0.027865029871463776, -0.01585421897470951, -0.10088278353214264, 0.06495074927806854, -0.011121690273284912, -0.18822267651557922, 0.06220197677612305, 0.014573518186807632, 0.1009979397058487, -0.17770099639892578, 0.02744048275053501, 0.25884950160980225, -0.07573254406452179, 0.056530557572841644, 0.09418941289186478, 0.10900402814149857, 0.0766090378165245, -0.15193040668964386, 0.08555394411087036, 0.054861944168806076, 0.04043005779385567, 0.010408200323581696, 0.12865149974822998, 0.06623665988445282, -0.04291033744812012, 0.14598166942596436, 0.11540861427783966, -0.059954684227705, 0.21731196343898773, 0.06333908438682556, 0.01948162354528904, -0.025998856872320175, 0.13275933265686035, -0.049027781933546066, -0.077117919921875, 0.06540610641241074, -0.10606744885444641, -0.05578622967004776, -0.053596071898937225, -0.08534520864486694, -0.22888264060020447, -0.06915609538555145, -0.06071099638938904, 0.038226597011089325, 0.03590584918856621, -0.22271955013275146, 0.05150006338953972, 0.04586772620677948, 0.0016009863466024399, -0.05047456920146942, 0.07577630877494812, -0.07509355247020721, -0.17765861749649048, 0.1666000932455063, -0.01031104288995266, 0.020707137882709503, 0.08693065494298935, -0.006895218975841999, 0.06815988570451736, -0.05043866112828255, 0.08506199717521667, -0.0417773574590683, 0.15080399811267853, 0.14181289076805115, -0.006146887317299843, 1.0418130190165491e-32, 0.008798329159617424, 0.021499264985322952, -0.019957656040787697, 0.1036980077624321, -0.024175409227609634, 0.10108236968517303, 0.05206631124019623, 0.012409084476530552, -0.020576240494847298, -0.2473319172859192, 0.04663233086466789, -0.0971093699336052, -0.014833122491836548, 0.02976265549659729, -0.10257909446954727, -0.0570756271481514, 0.076268270611763, 0.01368773728609085, -0.13327649235725403, 0.06712568551301956, 0.06555972993373871, -0.045963458716869354, -0.009134119376540184, 0.13482895493507385, -0.07126103341579437, 0.08203884959220886, -0.04653278738260269, 0.006520361639559269, 0.06292784214019775, 0.0039208801463246346, 0.008788371458649635, -0.08842745423316956, -0.008244807831943035, -0.3066651225090027, -0.19527257978916168, -0.06637194752693176, -0.0032402733340859413, -0.058810677379369736, -0.1249747946858406, 0.15456746518611908, -0.08508510142564774, 0.0821201503276825, -0.15295155346393585, -0.03451329097151756, 0.12061889469623566, -0.2021520435810089, -0.08129921555519104, 0.1126747578382492, -0.04080472141504288, -0.055402401834726334, -0.04823143780231476, -0.12755730748176575, -0.04992549866437912, 0.0724671334028244, -0.03390937298536301, 0.07936681061983109, -0.12234854698181152, -0.03360210359096527, 0.11222320050001144, 0.014201441779732704, 0.09075739979743958, 0.051395200192928314, 0.09469549357891083, -0.04242585971951485, -0.07931502908468246, 0.004106744658201933, 0.01776176691055298, -0.012578297406435013, -0.13369999825954437, -0.030371639877557755, 0.12557020783424377, 0.004487691447138786, 0.13829262554645538, 0.017834698781371117, -0.09577563405036926, -0.07594874501228333, 0.03236444666981697, 0.3399602770805359, 0.020273445174098015, -0.10143214464187622, -0.0790238305926323, -0.07970783859491348, 0.04842128977179527, 0.17232723534107208, 0.0196821428835392, -0.08403849601745605, 0.10409443080425262, -0.03839147463440895, -0.20310141146183014, 0.09659935534000397, 0.030173175036907196, -0.10245607793331146, -0.008019998669624329, 0.11523377895355225, 0.055004265159368515, -1.1800186816418086e-32, -0.028747886419296265, -0.05027477443218231, 0.04982887953519821, -0.10663385689258575, 0.006224070210009813, 0.1778365671634674, 0.08298508822917938, -0.031196268275380135, 0.10635203123092651, -0.24107491970062256, -0.01803002879023552, 0.03921163082122803, 0.03935927897691727, -0.08992001414299011, 0.025577455759048462, 0.15931743383407593, -0.14787787199020386, 0.03795876353979111, -0.11709930002689362, 0.0767747014760971, 0.06876903772354126, 0.02973647601902485, 0.00485028512775898, 0.10991603136062622, 0.16792213916778564, 0.055700331926345825, -0.07877573370933533, 0.02931719832122326, 0.017224622890353203, -0.007994220592081547, -0.14003029465675354, 0.038663286715745926, -0.2375025749206543, -0.08865498006343842, -0.05616199970245361, 0.16012530028820038, 0.08177128434181213, -0.03134506195783615, -0.01801811344921589, 0.04335328936576843, -0.09532153606414795, 0.05817251652479172, -0.053671695291996, -0.026437468826770782, -0.07139682024717331, 0.05715607851743698, 0.010191462934017181, -0.03869181126356125, 0.15034684538841248, 0.015586189925670624, 0.002534516155719757, 0.037646181881427765, 0.10802574455738068, 0.12422424554824829, -0.11101734638214111, -0.10687780380249023, 0.051553018391132355, -0.04165919870138168, -0.15419510006904602, -0.03556621074676514, 0.07532660663127899, -0.061856746673583984, -0.1326083540916443, 0.04634380340576172, 0.014449525624513626, 0.1575644463300705, -0.046757772564888, -0.0811777412891388, 0.1469377726316452, -0.15709009766578674, -0.21953654289245605, -0.15448015928268433, 0.08672790229320526, -0.0632489025592804, 0.029063653200864792, 0.04746030271053314, 0.08033238351345062, -0.17601008713245392, -0.037952013313770294, -0.08069738000631332, -0.15837141871452332, -0.02554634027183056, -0.06629280745983124, 0.004103832878172398, -0.07923099398612976, -0.011154519394040108, 0.12052494287490845, -0.06945955008268356, 0.02729540318250656, 0.0661504715681076, -0.12888087332248688, -0.021291092038154602, -0.06659567356109619, 0.10869129002094269, 0.14221714437007904, -1.0126760940920576e-07, 0.09810257703065872, -0.1496875286102295, 0.02144469879567623, -0.03184709697961807, -0.019050898030400276, -0.23459966480731964, 0.030555162578821182, 0.025107288733124733, -0.048129282891750336, 0.07704736292362213, 0.06559783220291138, 0.22738292813301086, 0.04742991924285889, -0.07233104109764099, 0.035314396023750305, -0.06419014930725098, 0.10938213765621185, 0.06692105531692505, -0.036268655210733414, 0.03292279690504074, -0.029426831752061844, -0.05988152325153351, 0.03111089952290058, -0.08644650876522064, 0.01669958047568798, -0.0587117001414299, 0.20270492136478424, -0.010411390103399754, -0.0719897672533989, 0.02007874846458435, -0.033531855791807175, -0.0707024559378624, 0.05424429476261139, 0.1062762588262558, -0.0014345677336677909, -0.09711259603500366, -0.010530051775276661, 0.1748119592666626, 0.05409013479948044, 0.13925790786743164, -0.04882185906171799, -0.14040669798851013, -0.011144314892590046, 0.0072074756026268005, 0.004872770980000496, -0.058352597057819366, -0.11436332762241364, 0.07418074458837509, 0.07181653380393982, -0.02659856528043747, -0.06022370606660843, -0.01408310979604721, 0.09077925235033035, -0.16152137517929077, -0.04276835918426514, 0.08230660855770111, 0.022842561826109886, -0.018207861110568047, 0.13410133123397827, -0.037995003163814545, 0.08322519063949585, -0.05191579461097717, 0.23415374755859375, 0.04809854179620743], "changes": {"1wk": 7.6487247341312, "1mo": 6.090649175973377}}]